An increase in pulsatile release of LHRH is essential for the onset of puberty. However, the mechanism controlling the pubertal increase in LHRH release is still unclear. In primates the LHRH neurosecretory system is already active during the neonatal period but subsequently enters a dormant state in the juvenile/prepubertal period. Neither gonadal steroid hormones nor the absence of facilitatory neuronal inputs to LHRH neurons is responsible for the low levels of LHRH release before the onset of puberty in primates. Recent studies suggest that during the prepubertal period an inhibitory neuronal system suppresses LHRH release and that during the subsequent maturation of the hypothalamus this prepubertal inhibition is removed, allowing the adult pattern of pulsatile LHRH release. In fact, ␥-aminobutyric acid (GABA) appears to be an inhibitory neurotransmitter responsible for restricting LHRH release before the onset of puberty in female rhesus monkeys. In addition, it appears that the reduction in tonic GABA inhibition allows an increase in the release of glutamate as well as other neurotransmitters, which contributes to the increase in pubertal LHRH release. In this review, developmental changes in several neurotransmitter systems controlling pulsatile LHRH release are extensively reviewed. (Endocrine Reviews 22: 2001) 
I. Introduction

P UBERTY is defined as the transient period between
childhood and adulthood during which reproductive function is attained. During this period the secondary sexual characteristics appear, the adolescent growth spurt occurs, the gonads start to produce mature gametes (sperm or oocytes) capable of fertilization, and major psychological changes occur (1) . In the last two decades, it has become apparent that puberty begins when the pulsatile release of LH releasing hormone (LHRH, also called GnRH) increases. The hypothalamic decapeptide, LHRH, stimulates pituitary release of LH and FSH, which are essential for the production of mature gametes and gonadal steroid secretion. Thus, the question of "what triggers the onset of puberty?" becomes rather the question of "what triggers the pubertal increase in LHRH release?" Since control of pulsatile LHRH release occurs within the hypothalamus, the answer to the latter question requires a neurobiological approach in animal models. Although many excellent reviews on the mechanism of the onset of puberty are available (2) (3) (4) (5) (6) , in this article we will examine the mechanism of puberty from a neurobiological perspective with an emphasis on its developmental aspect. Our discussion will focus on events in the nonhuman primate as a model for humans, but we will review data from other species, particularly from the rat, a common laboratory rodent.
Puberty is also associated with several neurological and reproductive disorders. For example, it has been documented that the onset of schizophrenia occurs during late puberty to early young adulthood (7) , precocious puberty is often associated with epilepsy in children (8, 9) , and the new onset of epileptic seizures tends to occur early in life as well as during the adolescent period (10) . In addition, taking into consideration the recent view that polycystic ovarian syn-drome originates during the pubertal stage (11, 12) , it is possible that an irregularity of the normal control of pulsatile LHRH release during puberty may be a cause of the polycystic ovarian syndrome, although this is highly speculative at this time. Therefore, it is our hope that this article will be helpful for understanding disorders in humans, including precocious puberty and delayed puberty, and the neuropathogenesis of the clinical disorders associated with puberty.
II. Description of Puberty
Physical and hormonal changes associated with puberty have been used as signs of sexual maturation. First appearance of pubic hair and enlargement of the breasts occurs at 8 -10 yr of age (2, 13, 14) . Pubic and axillary hair growth is primarily due to a pubertal increase in adrenal androgen (adrenarche), which occurs independently from pituitarygonadal maturation [gonadarche (15) ], whereas breast development is due to an increase in ovarian estrogens (2) . Subsequently, menarche occurs at an average age of 11-13 yr due to a further increase in ovarian estrogens (2, 13, 14) . Based on development of the breasts and pubic hair, Tanner (16) has developed standards for puberty in girls. Because an increase in estrogen during the early stage of puberty stimulates epiphyseal growth, accelerated growth (the pubertal increase in height velocity) is the first sign of puberty in individual girls (2) .
In boys, an increase in testicular size occurs at 9.5-13.5 yr (average 12 yr) of age (17) , which is followed by the growth of pubic hair and of the penis (16) . Testicular growth is due to a thickening of the seminiferous tubular lining, the formation of a lumen, and the differentiation and growth of Sertoli and Leydig cells, resulting in a volume increase in the Leydig cells. Tanner (16) also has established standards for pubertal development in boys.
In the female rhesus monkey, the first physical signs of puberty are a slight increase in growth velocity and nipple size, and development of perineal sex-skin color, which occurs at 25-28 months of age (18) . The increase in nipple size and perineal sex skin development further progresses, and menarche occurs at 28 -32 months of age. Several episodes of menstrual cycles occur after menarche (18) without ovulation, and first ovulation occurs at 42-50 months of age (18 -22) . After first ovulation, the ovulatory cycles in the rhesus monkey often exhibit a short luteal phase. Previously, we designated the period before any signs of puberty as the prepubertal stage, the period between first signs of puberty and menarche as the early pubertal stage, the period between menarche and first ovulation as the midpubertal stage, and the period between first ovulation and full maturity as the late pubertal stage (18) . In female rats, vaginal opening, which occurs around postnatal (P) day 35-37 (P35-P37), and which is usually accompanied by the first ovulation, is a marker of puberty. However, because vaginal opening often occurs without first ovulation under experimental conditions, direct observations of ova in oviducts or corpora lutea formation on the ovary ensure the documentation of true puberty.
In male rhesus monkeys testicular descent into the scrotum occurs slightly after 30 months of age. Subsequently, testicular volume starts to increase. This increase continues until approximately 48 months of age, when full spermatogenesis is observed (3) . Male rats become fertile at P42-P45, which is accounted as the time of puberty (4).
III. When Does the LHRH Neuronal System Mature?
A. Embryonic and fetal periods
Studies in the mouse (23, 24), rhesus monkey (25, 26), and human (27) indicate that LHRH neurons originate from the olfactory epithelium during the gestational period. In the rhesus monkey, LHRH cells are found in the olfactory pit as early as at embryonic (E) day 32 (E32) and commonly at E34 -E36 (Refs. 25, 26, and 28 and Fig. 1 ). LHRH cells migrate along the nasal septum and terminal nerve, enter the forebrain at E38 (26), and subsequently migrate into the basal hypothalamus of the rhesus monkey by E47 (25). The basic distribution pattern of LHRH neurons in the brain is already established at E55 (25, 26, 29), although LHRH cell migration into the preoptic area (POA) and hypothalamus continues after E55 until the last trimester. The gonadotropes are found in the pituitary at E50 (25), and sex-specific gonadal steroids are detectable in the umbilical cord at E70 (30), suggesting that LHRH cells are functioning at E50 -E70. However, activity of LHRH neurons may not be high until close to term; pro-LHRH mRNA is detectable in LHRH cells at E38 -E50, but does not increase significantly until E135 (25). Gonadectomy at E98 -E104 results in the elevation of LH and FSH in male monkeys, but not in female monkeys (31), indicating that the negative feedback system is operative in the male hypothalamo-pituitary-gonadal axis during the second trimester.
A similar ontogenic picture of the reproductive neuroendocrine system has been described in humans (32). In human fetuses, LHRH cells are found in the olfactory placode as early as embryonic (E) week 5.5 ( Fig. 1) , although a majority of LHRH cells originate in the olfactory pit at E week 6.0 -6.5. LHRH cells enter the forebrain through the terminal nerve by E week 6.5, and they migrate into the hypothalamus by E week 9.0 (Refs. 27 and 33; C. Quanbeck and E. Terasawa, unpublished observation).
FSH and LH are detectable in the human pituitary by E week 10, and their content increases until E week 25-29. The pituitary starts to release gonadotropins into the general circulation by E week 11-12. Circulating gonadotropins reach peak levels at midgestation, and subsequently both LH and FSH levels decline during late gestation (34 -37). The gonadotropes in human fetuses respond to LHRH by releasing LH and FSH both in vivo and in vitro (38 -41). A sex difference in gonadotropin levels is seen during midgestation: pituitary content and circulating concentrations of LH and FSH in female fetuses are higher than those in male fetuses (34, (42) (43) (44) . Since circulating testosterone levels are high in male fetuses as compared with circulating estrogen levels in female fetuses during midgestation, both the sex difference in gonadotropin levels and the decrease in gonadotropin levels toward late gestation in fetuses are attrib-uted to the development of the negative feedback mechanism by the gonadal steroid hormones from the fetal gonads as well as from the placenta (2) . A report that castration in male rhesus monkeys at E98 -104 increases circulating gonadotropins to levels as high as those in female monkeys at similar ages (30, 31) supports this notion. Negative feedback by ovarian steroids is operative in the human female fetus during late gestation when estrogen secretion is elevated (32, 34). In sheep fetuses during late gestation, LH release is pulsatile, and orchidectomy in males, but not ovariectomy in females, results in an increase in the pulse amplitude of LH (45).
B. Postnatal maturation
Although the distribution pattern of LHRH neurons is already established before birth in most species in which it has been studied, the function, morphology, and biosynthesis, as well as synaptic connectivity of LHRH neurons, may not be mature until the time of puberty. In rats it has been shown that the number of LHRH neurons with a wrinkled contour increases, while the number of LHRH neurons with a smooth contour decreases at the age of puberty (46). Further, in rats and mice, LHRH mRNA levels increase gradually with age, and significant increases occur at P15-P30 depending on sex and experimental conditions (47-51). These observations imply that LHRH neurons in rodents may receive more intensive innervation from other neurons, and that LHRH gene expression matures after birth, but before puberty. In contrast, in primates, available data indicate that LHRH neurons are mature well before the onset of puberty: there are no differences in the number (52) or the shape of LHRH neurons (53) or in the LHRH mRNA levels (54) between juvenile and adult monkeys. Further, we have shown that electrical stimulation of the medial basal hypothalamus (MBH) in prepubertal monkeys, in which basal LHRH release is very low, induces LHRH release similar to that observed in pubertal monkeys (55). However, it is possible that LHRH neurons in primates undergo subtle developmental changes during the juvenile period, as shown by two recent reports: 1) perikarya of LHRH neurons located in the MBH of early pubertal female monkeys are invested with more glial sheathes than in adult cyclic female monkeys (56); and 2) a decrease in the area occupied by synapses onto LHRH neurons occurs in adult castrated male monkeys as compared with prepubertal castrated male monkeys (57), indicating that subtle changes may occur in the innervation pattern of LHRH neurons. Nonetheless, it is problematic to discuss the significance of these discrepancies, because ontogenic changes in morphology and gene expression of LHRH neurons in primates have not been systematically studied, and in both rodents and primates the issue as to how the presence or absence of gonadal steroids affects ontogeny of morphology and gene expression of LHRH neurons has not been assessed.
IV. What Determines the Timing of Puberty?
A. Hormonal changes during the neonatal and juvenile periods
Circulating LH levels in human male neonates abruptly increase within the first few minutes after birth, followed by an increase in serum concentrations of testosterone during the first 3-21 h (58). High levels of LH in the human male infant decline within 6 months and remain low until the beginning of puberty. FSH levels in human males are slightly FIG. 1. Ontogeny of the LHRH-pituitary-gonadal system before birth until after the onset of puberty in female rhesus monkeys (top) and in female humans (bottom). Days and months are used as the scale for the gestational period and after birth in monkeys, respectively, whereas weeks and years are used as the scale in humans. The age of events indicated in this figure is approximate.
elevated for the first 3 postnatal months, after which they become low (59, 60). Circulating levels of testosterone are also elevated for 2-4 months postnatally (61). In contrast, in female neonates LH levels are only slightly elevated during the first few months of life, but FSH levels are high for the first 5 months (59, 60). After the first 6 months of life, circulating levels of FSH, LH, and gonadal steroids are all low, and the hypothalamo-pituitary-gonadal system enters a quiescent stage until the time of puberty. Plasma concentrations of LH and FSH in infants with gonadal dysgenesis are strikingly elevated, because of the absence of the negative feedback loop (59, 60, 62, 63). However, the elevated level of gonadotropin in patients with gonadal dysgenesis declines during the juvenile period, as seen in eugonadal children.
In infantile male monkeys, circulating LH and testosterone are elevated during the first 2-3 postnatal months (64, 65), and diurnal variation of testosterone, quantitatively similar to that seen in sexually mature adults, is observed (66). Bilateral orchidectomy at 1 week of age results in an increase in LH and FSH secretion, with a pulse pattern very similar to that in castrated adult males (67). Plant (68) suggests that the hypothalamo-pituitary axis governing testicular function in males is fully mature by the neonatal stage of development. Both LH and FSH levels in male monkeys decrease after 3-4 months of age (69, 70). By contrast, in female monkeys circulating LH is only slightly elevated or not elevated during the first 3 months (65), and the negative feedback mechanism appears to be only partially operative in the late gestational period through the neonatal period. A moderate elevation of estrogen levels is observed during late gestation through the neonatal period in females (65). Ovariectomy in females at 1 week of age induces a truncated and abbreviated elevation of LH release with slower pulse frequency, when compared with those in orchidectomized male infants (71). It is possible that the LHRH neurosecretory system in female monkeys during the neonatal period is less mature than in males (71). Alternatively, in females, central inhibition to the LHRH neurosecretory system (see below) may start earlier than in males and may not be as complete as in males. Nevertheless, at 4 -6 months of age, the LHRH neurosecretory system in both sexes enters a quiescent state, which persists until the time of puberty (18, 68, 70, 72) .
B. Hormonal changes at the onset of and during puberty
Before the onset of puberty, LH and FSH levels are low, but a highly sensitive assay indicates that circulating LH and FSH levels in prepubertal children are pulsatile, with slightly higher values at night than morning (73-80). In both boys and girls, preceding the physical signs of puberty, LH and FSH levels become elevated, pulsatility of these hormones becomes more pronounced, and the nocturnal increase in gonadotropin release is enhanced (75-78, 81, 82). Both pulse frequency and amplitude of LH release increase at this stage as well (77, 78) .
Similarly, the first hormonal sign of puberty in female rhesus monkeys appears several months earlier than menarche (18, 83) . During the early pubertal period, mean FSH levels increase, followed by an increase in mean LH levels. Basal levels of LH and the amplitude and frequency of pulsatile LH release increase, and a circadian fluctuation (nocturnal increase) of LH emerges. The pubertal increase in gonadotropin release stimulates estrogen secretion from the ovary, resulting in nipple growth, sex skin development, and subsequently menarche (18, 83) . Due to an increase in circulating estrogen, FSH levels are suppressed. During the midpubertal period, the nocturnal increase in LH becomes more pronounced, and basal LH levels and the amplitude of LH pulses further increase. A periodic increase in estrogen causes menstrual cycles, although data with laparoscopy indicate that periodic vaginal bleeding is not due to cyclic ovulation (83). Circulating estrogen during this developmental period sometimes reaches the preovulatory level, but there is no LH surge until the time of first ovulation (18) . This is called pubescent infertility. After the age of first ovulation, both basal LH levels and LH pulse amplitude decline, and the nocturnal increase in LH release disappears (18) .
These changes in the LH release pattern during puberty are the result of developmental changes in pulsatile LHRH release, since pulsatile LHRH release also increases (84). The pulse frequency of LHRH release increases at the onset of puberty and remains elevated throughout the pubertal period (Refs. 84 and 85 and Fig. 2 ), while the pulse amplitude of LHRH release starts to increase at the transition period between prepuberty and puberty and continues to increase throughout puberty until first ovulation occurs (84, 85). The nocturnal increase in LHRH release is readily observed during the early pubertal period and becomes increasingly prominent during the midpubertal period, while during the prepubertal period, nocturnal increases in LHRH release are seldom seen (84, 85). These facts indicate that the hormonal profiles appear as gradual changes throughout puberty and that the development of the LHRH neurosecretory system or its regulatory systems is essential for the onset of puberty.
C. Positive feedback effects of estrogen on the LH surge
Because the preovulatory LH surge induces ovulation from a Graafian follicle, the age at which estrogen induces the first LH surge is an important consideration for the timing of puberty. In rats, the youngest age that responds to estrogen is between P15 and P20 (86 -89), and the youngest age that PMSG induces ovulation in rats through ovarian steroids is also P15-P20 (90 -93). It has been reported that in humans and monkeys estrogen injection does not induce an LH surge until after menarche (94 -96). We have also confirmed that positive feedback effects of estrogen on the LH surge in ovariectomized (OVX) female rhesus monkeys do not occur until the age of menarche, when basal LH levels rise to a certain level (97). Moreover, in the same study it was found that baseline LH levels, which gradually increase during the course of puberty, are positively correlated with the magnitude of the LH surge as well as with the peak latency of the LH surge. That is, at the age of menarche, when baseline LH levels are low, the size of the estrogen-induced LH surge is small and the peak latency to the LH surge is long, whereas at the age of first ovulation, when the baseline LH level is highest, the largest LH surge with the shortest peak latency occurs (97). These data suggest that the ability of the hypothalamus to respond to positive feedback effects of estrogen is an expression of LHRH secretory activity, which increases continuously from the onset of puberty until the age of first ovulation. An increase in the amplitude of the estrogeninduced LH surge during puberty has also been reported in sheep (98). Since a dramatic increase in LHRH release occurs during the estrogen-induced LH surge in pubertal monkeys (99) and in adult sheep (100 -103), an integrated circuit that controls the releasability of LHRH from LHRH neurons is essential for the positive feedback effects of estrogen. Although the nature of the neuronal circuit involved in estrogen-induced LHRH release in primates is unknown, it is clear that the LHRH neuronal system responsible for estrogen action undergoes maturational changes during puberty.
There is a controversy as to the sites of action of estrogen in nonhuman primates. In a series of studies in adult female monkeys, Knobil and colleagues (104 -110) have shown that the estrogen-induced LH surge does not require the hypothalamus other than as a supply source of pulsatile LHRH release: 1) the positive feedback effects of estrogen occur in monkeys with complete deafferentation or isolation of the MBH (105, 106); 2) whereas lesions of the MBH abolish LH surges (107); 3) pulsatile infusion of LHRH into animals with lesions in the MBH is sufficient to result in the estrogeninduced LH surge (108); and 4) estrogen can induce an LH surge in animals with lesions in the MBH up to 48 h after cessation of pulsatile LHRH infusion (109, 110). In support of the pituitary site of estrogen action in primates, Ferin et al.
(111) report that isolation of the pituitary gland from the hypothalamus by stalk section with a Silastic barrier in monkeys fails to block the estrogen-induced LH surge. In contrast, Spies and colleagues (112) report that the hypothalamus is essential for estrogen action in monkeys, based on the observation that stalk section with a Teflon barrier blocks the estrogen-induced LH surge (112), and the estrogen-induced LH surge or the preovulatory LH surge is accompanied by an increase in pulsatile LHRH release (113, 114). The estrogeninduced LHRH increase has also been reported by another group in OVX monkeys (115) as well as by us in pubertal monkeys (99). Without going into further detail on this controversy, it is safe to conclude that, in the rhesus monkey, estrogen stimulates an increase in LHRH release from the hypothalamus, but estrogen also stimulates an LH surge directly from the gonadotropes. Nonetheless, stimulation of pulsatile LHRH release is essential for the functional gonadotropes, and an increase in pulsatile LHRH release triggers puberty; the establishment of the neuronal mechanism responsible for the adult type of pulsatile LHRH release is obligatory to the positive feedback effect of estrogen during the pubertal period.
D. Two hypotheses on the mechanism of the onset of puberty
Two hypotheses have been proposed for the mechanism of the onset of puberty. The first one is commonly called the "gonadostat" hypothesis, or "differential sensitivity to ovarian steroids" hypothesis. More than a half-century ago, this
Schematic illustration of postnatal changes in LHRH release and neurotransmitter events that occur in the hypothalamus in association with puberty in nonhuman female primates. The LHRH neurosecretory system appears to be active during the infantile period, but is suppressed by an inhibitory mechanism comprising GABA neurons. At the onset of puberty, a reduction in GABA inhibition and a subsequent increase in glutamate excitation of LHRH neurons result in the pubertal increase in the pulse frequency, pulse amplitude, and baseline levels of LHRH, which trigger puberty. Furthermore, a higher nocturnal level of LHRH release, shown by hatched bars, becomes particularly prominent. After the onset of puberty, other stimulatory neurotransmitters such as NPY and NE take part in control of LHRH neurons, resulting in further increases in the pulse amplitude and baseline level of LHRH release, until the time of first ovulation. The nocturnal increase in LHRH release and LHRH pulse amplitude are reduced to the adult level, perhaps due to participation of inhibitory neurotransmitters, such as opioids. Stippled bars indicate morning levels of LHRH. In males the LHRH neurosecretory system is fully mature during the infantile period, but is suppressed completely during the juvenile period. Recently, it has been hypothesized that NPY is an inhibitory neurotransmitter before puberty in males. (See text for details.)
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NEUROBIOLOGY OF PUBERTYhypothesis was proposed by Dohrn and Hohlweg (117), based on the observation that, compared with adults, in immature rats a smaller dose of estrogen can suppress the castration-induced changes in the gonadotropes. According to this hypothesis, puberty occurs when the regulating system for gonadotropin secretion becomes desensitized to steroid feedback during sexual maturation, and the shift in sensitivity to steroids permits gonadotropin secretion. It has been shown that in rats and sheep, "escape of suppressed LH secretion by gonadal steroids" occurs at the onset of puberty (118, 119), although Ojeda and colleagues (120) argue that the shift in the sensitivity to gonadal steroids does not occur until after the first proestrous surge in rats. Escape from the negative feedback effect of estrogen occurs in monkeys during the midpubertal stage, but not at the onset of puberty (121, 122). Thus, the hypothesis is not applicable to primates (see below), but it appears to be applicable to sheep (see Ref. 5) . The second hypothesis is that sexual quiescence before the onset of puberty is due to central inhibition of LHRH release, independent of the negative feedback of gonadal steroids, and that an increase in pulsatile LHRH release triggers puberty (18, 123, 124 ). This hypothesis is based on the fact that gonadotropin secretion in gonadectomized monkeys and in human subjects with gonadal dysgenesis is elevated during the neonatal period, but subsequently suppressed until the time of puberty. This hypothesis has been supported by the direct measurement of LHRH in the stalk-median eminence (S-ME) of rhesus monkeys using a push-pull perfusion method. For example, ovariectomy of prepubertal female monkeys fails to stimulate pulsatile LHRH release, whereas ovariectomy of early and midpubertal female monkeys induces the postcastration-induced LHRH release (85). The age of the pubertal increase in LHRH release in OVX monkeys is essentially similar to that in ovarian intact counterparts (85), indicating that the pubertal increase in LHRH release is independent of the ovarian steroids. Therefore, maturational changes in the hypothalamic mechanism that controls pulsatile LHRH release, independent of the negative steroid feedback mechanism, are responsible for the onset of puberty. In addition, estrogen injection in gonadectomized females of pubertal age readily suppresses pulsatile LHRH release, whereas the same treatment does not cause any significant change in LHRH release in gonadectomized females of prepubertal age (125), suggesting that the LHRH neurosecretory system is insensitive to negative feedback effects of estrogen before the onset of puberty. In fact, the LHRH neurosecretory system increases its sensitivity to ovarian steroid feedback after the onset of puberty.
The gonadostat hypothesis is, in part, a historical product of the time during which the brain-pituitary unit had been considered as a "black box." The pubertal increase in release of LH and LHRH can occur independent of the presence or absence of gonadal steroids, as seen in rhesus monkeys. The pubertal increase in LH release can also be influenced by the presence of gonadal steroids, as shown in sheep, although the degree to which the pubertal increase in LHRH release is influenced by the gonadal steroids has not been quantitatively assessed. Perhaps, the term "gonadal steroid-dependent LHRH increase," first introduced by Reiter and Grumbach (123), reflects the gonadostat hypothesis most accurately.
In humans, Grumbach and colleagues (2, 123) suggest that a gonadal steroid-dependent LHRH increase also occurs at the onset of puberty, since smaller amounts of gonadal steroids are effective in suppressing FSH and LH levels in prepubertal children than in adults (126, 127). It is possible during the juvenile period in humans that a small amount of LHRH release from the hypothalamus maintains the minimum levels of gonadotropin secretion, which is susceptible to the negative feedback effect of steroid hormones. In contrast, we observed no changes in either LH or LHRH suppression after estrogen treatments in OVX prepubertal monkeys (99, 128). Therefore, the difference in humans and rhesus monkeys can be attributed to a subtle species difference in the mechanism of the onset of puberty.
E. Species differences in the mechanism of the onset of puberty
An increase in pulsatile LHRH release is essential for the pubertal increase in gonadotropin secretion and subsequent gonadal stimulation. A pulsatile infusion of LHRH into sexually immature monkeys (129) and guinea pigs (130) results in precocious puberty. Further, an increase in pulsatile LHRH release has been shown to occur at the onset of puberty not only in monkeys (84), in which the removal of central inhibition triggers puberty (see below), but also in sheep (5) and rats (131), in which a shift of the sensitivity to ovarian steroids appears to be responsible for the onset of puberty.
Nevertheless, the mechanism initiating puberty appears to differ between primates and other species: 1) in monkeys, castration induces an elevation of gonadotropin release during the neonatal period and after the onset of puberty, but not during the juvenile period before the onset of puberty (3), while in rats and sheep the castration-induced elevation of gonadotropin release occurs from the neonatal period throughout life (4, 5) ; and 2) the N-methyl-d-aspartic acid (NMDA)-induced precocious puberty in monkeys does not lead to normal reproductive cycles as adults after cessation of the drug infusion (132), while in rats the NMDA-induced precocious puberty continues on to cyclic ovulation (133, 134). However, this may occur because by the time the treatment ends, these animals are near the normal age of puberty and not because of an actual species difference. In primates, LHRH neurons are under tonic central inhibition during the juvenile period, and removal of this inhibition is necessary before the activation of central excitations can allow the initiation of puberty (128, 135). In contrast, in rats, tonic central inhibition, equivalent to that in primates, may not exist, and the establishment of glutamatergic and other facilitatory neuronal systems is required for the onset of puberty (136).
Species differences between the rhesus monkey and rat may also be seen in synaptogenesis. Synaptogenesis in the hypothalamus of the rat increases from the neonatal period to puberty (137-140) as it does in the cerebral and cerebellar cortices (141-143), although a part of the pubertal increase in synaptogenesis in rat hypothalamus is probably due to the pubertal increase in estrogen (140), as observed in estrogen-primed OVX rats (144). In contrast, according to the studies by Rakic and colleagues (145-148), synaptogenesis in the cerebral cortex of rhesus monkeys dramatically increases after birth, reaches a plateau at 2-4 months of age, and declines slightly through the juvenile period followed by a substantial decrease at the age of puberty, to adult levels (145). Interestingly, the developmental changes in synaptogenesis are uniform among the different cortical regions (146) and the dentate gyrus (147) as well as different layers of the neocortex (148). Moreover, the density of neurotransmitter receptors such as dopaminergic, adrenergic, serotoninergic, cholinergic, and ␥-aminobutyric acid (GABA)ergic receptors in the cortex also reaches a maximum level between 2 and 4 months of age and declines thereafter, similar to changes in synaptogenesis (145). These data are interpreted by the authors to indicate that overproduction of synapses and neurotransmitter receptors in the neocortex are eliminated by a gene-regulated mechanism and that this elimination is critical to the establishment of specific cortical functions (145, 149). Although the studies by Rakic and colleagues are primarily focused on the perinatal period, and although synaptogenesis in the hypothalamus with emphasis on the onset of puberty has yet to be investigated, the developmental time course of synaptogenesis in the neocortex is strikingly similar to that of gonadotropin release in the neonatally gonadectomized rhesus monkey. It is possible that a similar decrease in synaptogenesis in the hypothalamus occurs during sexual maturation in primates. If the elimination of predominantly stimulatory synapses to LHRH neurons occurs during the first few months of life, this could lead to the suppression of LHRH release during the first few months of life, and if the elimination of predominantly inhibitory synapses to LHRH neurons occurs before the onset of puberty, this could lead to the pubertal increase in LHRH release. Moreover, a decrease in inhibitory synapses at the onset of puberty may allow the synaptogenesis of facilitatory neurons [e.g., glutamate and norepinephrine (NE)] to establish a specialized function. In support of our view, Perera and Plant (57) reported that a decrease in the area occupied by synapses onto LHRH neurons occurred in adult castrated male monkeys as compared with prepubertal male castrated monkeys, although these authors did not qualify the type of synapses. Nonetheless, the hypothesis that the onset of the pubertal increase in LHRH release is due to the elimination of inhibitory neurons and the subsequent establishment of selective neuronal pathways and/or neuronal networks that are responsible for the adult pattern of LHRH release in primates is yet to be tested. Certainly, it is possible that developmental changes in synaptogenesis in female primates is also influenced by the pubertal increase in estrogen, as recently described in adult OVX monkeys by Horvath and Naftolin and colleagues (150). The degree to which changes in synaptogenesis are attributed to developmental or to the pubertal increase in estrogen should be differentiated.
V. Neurobiology of Puberty
Most neurotransmitters and neuromodulators possess both excitatory and inhibitory properties depending on several factors, such as composition of the neurocircuit, developmental stage, and hormonal environment. Therefore, the classification of inhibitory and stimulatory neurotransmitters in this article is based on the general feature of control of pulsatile LHRH release in the adult, and no neuroactive substance should be confined to a single category.
A. Inhibitory neurotransmitters
In primates, central inhibition of the LHRH neurons is present before the onset of puberty, and the removal or diminution of central inhibition triggers the onset of puberty. This concept is based upon the following: 1) gonadotropin secretion in agonadal humans (62, 63, 151) and neonatally gonadectomized monkeys remains suppressed until the onset of puberty despite the absence of the gonadal steroids (18, 70) ; and 2) precocious puberty occurs in humans and primates with hypothalamic lesions (see Ref. 83 ). Therefore, the search for neuronal substrates responsible for inhibition of LHRH release in the prepubertal period has begun. The first neuromodulators that were extensively studied were endogenous opioids, but evidence indicates that these were not likely candidates for the LHRH suppresser before the onset of puberty. Subsequently, the role of GABA was studied.
Endogenous opioids.
The role of opioids in reproductive function has been well reviewed by others (152-157). Because opioid substances suppress pulsatile LH release (158 -160), and because the low frequency of LH pulses during the luteal phase, pregnancy, or the negative feedback phase of estrogen can be reversed in adults by the opioid antagonist, naloxone (161-167), a role for endogenous opioids in puberty has been proposed. In fact, it has been shown that the administration of naloxone stimulates LH release in prepubertal sheep as well as fetal sheep (168 -170). However, a careful study by Foster and colleagues (171) concludes that in sheep the pubertal decrease in sensitivity to inhibitory feedback effects of gonadal steroids before the pubertal increase in LH release is not causally related to opioid inhibition. In addition, both LHRH and ␤-endorphin (␤-END) levels in the median eminence of lambs with delayed puberty induced by food restriction are lower than in normal lambs (172), indicating that ␤-END is not an inhibitory neurotransmitter responsible for low LHRH release before the onset of puberty.
Similarly, in primates, among possible opioid neurotransmitters, ␤-END is an unlikely candidate for the prepubertal inhibition of LHRH release: 1) naloxone, an opioid antagonist, does not increase LH release until after the onset of puberty in chimpanzees (173); 2) effectiveness of naloxone in stimulating LH release increases greatly with the progress of puberty (174); 3) expression of POMC mRNA in the arcuate nucleus increases after puberty (54); and 4) the release of ␤-END from the S-ME increases during puberty concomitant with LHRH release (175). It is conceivable that the opioid system may not be active before the pubertal increase in estrogen, since the components of this system, such as the -opioid receptor, are activated by estrogen (176, 177). Hence, opioids seem to be a neuronal component controlling LHRH release in mature, but not in immature, animals and humans (Table 1 and Fig. 2) .
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NEUROBIOLOGY OF PUBERTY2. Inhibitory amino acid GABA. GABA is the dominant inhibitory neurotransmitter in the hypothalamus (178). Because of the physiological importance of GABA, especially through GABA A receptors, in puberty, we will discuss GABA and GABA A receptors in detail.
a. Biochemistry and molecular biology of GABA. Synthesis of GABA: In presynaptic neurons GABA is synthesized from glutamate by decarboxylation in the presence of glutamic acid decarboxylase (GAD), stored in vesicles, and released by exocytosis upon depolarization in the presence of extracellular Ca 2ϩ (179). Although GABA is also synthesized through other pathways, such as putrescine and ␥-hydroxybutyrate, they are considered to play a minor role (see Refs. 180 and 181). GABA synthesis occurs in two compartments: 1) GABAergic neuroterminals and 2) perikarya and dendrites. Glia do not synthesize GABA, but play a role in GABA metabolism by providing precursors and by taking up or degrading GABA overflows from the synapse (182).
GABA synthesis is controlled by the concentration of glutamate in the GAD-containing cellular compartments, although it is unclear how the glutamate concentration is linked to neuronal activity to control GABA synthesis and maintain the neurotransmitter pool, and how the availability of glutamate regulates physiological GABA synthesis in vivo (180, 181).
Two different forms of proteins have been reported as the GABA-synthetic enzyme GAD. Based on molecular weight they are named GAD67 and GAD65, which are derived from two respective genes (see Refs. 180, 181, and 183). The two cDNAs contain no contiguous identical sequences longer than 17 nucleotides (183), and the amino acid sequences of GAD65 and GAD67 from the rat brain are less similar than are sequences of each form in different mammalian species (184). Although both GAD forms are present in most brain regions, the distribution of the two GADs in the brain is not identical (185, 186). Immunocytochemical and in situ hybrid-ization studies suggest that GAD65 is more consistently localized in neuroterminals, whereas GAD67 is found throughout neuronal cells (184, 187). However, recent reports indicating that 1) GAD67 and GAD65 can form a heteromultimer (188); 2) GAD67 may be transported to neuroterminals together with GAD65 (189); and 3) immunoreactive GAD67, but not GAD65, is found in the neuroterminals of hippocampal granular cells (190) . The presence of GADs is not limited to the brain. GAD67 mRNA was found in the rat testis, while GAD65 mRNA was found in the rat oviduct (191) . Further, both GAD67 and GAD65 are present in pancreatic ␤-cells in humans, and a titer of GAD65 antibodies is elevated in patients with insulin-dependent diabetes mellitus (192) (193) (194) .
GAD67 and GAD65 exist in the enzymatically active holo form and inactive apo form, and conversion of holo-GAD67 or holo-GAD65 to and from apo-GAD67 or apo-GAD65 is determined by the presence of the cofactor, pyridoxal-5Ј-phosphate, which is influenced by physiological states as well as by experimental conditions (180, 183).
Recently, it has been hypothesized that vesicular release of GABA may be associated with GAD65, whereas nonvesicular release of GABA, which is mediated by the reversal of GABA transporters (see below), may be associated with GAD67 (199a) .
Reuptake of GABA: Elevated local concentrations of amino acid neurotransmitters in the synaptic cleft are actively removed by specific transporters, located on presynaptic terminals and surrounding glial cells, where the neurotransmitters are recycled. GABA transporters (GAT) are classified in the Na ϩ and Cl Ϫ -coupled transporter family. Four GABA transporters (GAT-1, GAT-2, GAT-3, and BGT-1) have been described (195) (196) (197) . GAT-1 is the predominant GABA transporter in the mammalian brain (197) , and specific GAT-1 antagonists increase extracellular GABA concentration in the rat thalamus (198) . Interestingly, the GAT-1 transcript contains an estrogen-responsive element (199) . It is possible, therefore, that the reduction of GABA concentration in the S-ME at the onset of puberty might be due to a developmentally regulated increase in GABA transporter activity. At this time there is no information on the role of GAT in puberty.
b. Molecular biology and pharmacology of GABA receptors. Three GABA receptors, GABA A , GABA B , and GABA C have been identified in the brain. The GABA A receptor is a pentameric membrane-spanning ligand-gated ion channel that permits Cl Ϫ entry into the cell upon binding with the neurotransmitter GABA (200 -202) , whereas the GABA B receptor is coupled to calcium and potassium channels, as well as an intracellular signaling pathway, via GTP binding proteins (203, 204) . The GABA C receptor is a Cl Ϫ pore and, according to current reports, is found predominantly in the vertebrate retina. GABA A receptors are modulated by allosteric agonists, benzodiazepines, barbiturates, neurosteroids (primarily metabolites of pregnane steroids), and ethanol, as well as polyvalent cations (205, 206) . GABA A receptors are composed of at least 18 genetically distinct subunits (␣1-␣6, ␤1-␤4, ␥1-␥4, ␦, , 1-2). An ␣-subunit, ␤-subunit, and ␥-subunit are all required to form a fully functional GABA A receptor (207, 208) , and the ␣1␤2␥2 arrangement is the most common in the brain.
The functional and pharmacological characteristics of a GABA A receptor are determined by the subunit composition (209 -211) . The spatial distribution of subunits in the brain differs, and the subunit composition varies from neuron to neuron (209, 210) . Further, the pattern of the subunit composition varies during prenatal and postnatal development (212) (213) (214) (215) (216) . Since GABA A receptors mediate GABA inhibition of LHRH release (217), it is particularly important to determine whether the subunit composition in the hypothalamus, especially on LHRH neurons, changes during maturation, related to the onset of puberty. It has been shown that in adult rats some LHRH neurons express the ␤ 3 -, but not ␣ 1 -or ␤ 2 -, GABA A subunits (218), and in peripubertal female rats some LHRH neurons express ␣ 1 -, ␣ 2 -, ␤ 3 -, and ␥ 2 -, but not ␥ 1 -subunits (219).
c. Developmental changes in GABA and GABA receptors. GABA and GAD: The concentration of GABA and the number of GABAergic neurons in the rat spinal cord increase from E13 to the second postnatal week and then decline by the third postnatal week (220). Similarly, GAD67 and GAD65 mRNAs in the rat spinal cord increase exponentially during embryonic development starting on E11 until the first postnatal week, but then decline during the second postnatal week to adult levels (221). In the rat striatum GAD65 mRNA increases until 2 weeks postnatally, and then declines toward adult levels, whereas GAD67 mRNA keeps increasing from 1 week postnatally until adulthood; thus, the ratio of GAD65 to GAD67 mRNAs is high at 1-2 weeks postnatally, and then levels off to the adult ratio by 3 weeks (222). In the mouse cortex, the number of GABA-positive cells decreases postnatally, although the timing of the declining pattern differs depending on the layers of the cortex examined (223). The increase in GAD and GABA concentrations during embryonic development is due to neurogenesis, whereas the postnatal decline is not likely due to cell death (224).
GAD65 and GAD67 mRNA levels and GABA concentrations in the rat POA increase with age between P1 and P15 (225-227) and increase further between P15 and P35-P40 (228, 229). However, developmental changes in GAD mRNA expression and GABA concentrations within the MBH require additional studies investigating the precise location of GABA neurons and a wider age window. Some reports show that GAD mRNA in the rat arcuate nucleus, but not dorsomedial nucleus, increases with age between P1 and P20 (227), and GABA concentrations in most areas of the brain, including the MBH, caudate-putamen, hippocampus, and amygdala, increase with age (225, 226), whereas other reports indicate GABA concentrations in the rat MBH (229) or in the rat POA/MBH (230) do not change with age between P15-P40.
Developmental changes in GABA and GAD in primates are not well studied, and there are conflicting data from the postnatal period. In the Japanese macaque, GAD concentration in the fetal cerebellum is very low during the second trimester, quickly increases 6.3-fold at full term, and further increases 2.2-fold by adulthood (231). GABA concentrations in the occipital cortex of rhesus monkeys increase 2-fold from
NEUROBIOLOGY OF PUBERTYthe fetal period (E70 -E150) to the neonatal period, but do not change further in adults (232). The number of GABA neurons in the visual cortex increases gradually between E110 and P160 in rhesus monkeys, but there are no descriptions at older ages (233, 234). GAD activity in the human neocortex sharply increases at birth and continues to increase until 1 yr of age, after which it declines gradually until pubertal age and then slightly increases at adulthood (235, 236). Recently, Urbanski et al. (237) reported that the distribution pattern and concentration of GAD67 and GAD65 mRNAs in hypothalamic nuclei assessed by in situ hybridization in juvenile (ϳ0.6 yr of age) gonadally intact male rhesus monkeys were not different from those in adult (ϳ10 yr of age) male monkeys, and a report by Plant and colleagues (238) indicates that GAD mRNA levels in the basal hypothalamus of juvenile castrated male rhesus monkeys did not differ from those in adult castrated male monkeys. Although these data do not appear to support the hypothesis that GAD plays an important role in puberty (see below), more precise developmental studies with the exact regional distribution pattern of GABA neurons in nonhuman primates, including in females, are needed before conclusions can be drawn. GABA release: GABA release in the POA measured by push-pull perfusion decreases between P26 and P35 in female rats (239). Similarly, in female rhesus monkeys GABA release in the S-ME decreases concomitant with the pubertal increase in LHRH release (217, 240). These findings suggest that elevated GABA in the POA in female rats and in the S-ME in female rhesus monkeys may contribute to the suppression of LHRH release before the onset of puberty.
GABA A receptors and their subunit composition: Rakic and colleagues (145) report that the density of GABA A receptors in all five layers of the cerebral cortex of rhesus monkeys increases after birth, reaching a maximum level between 2 and 4 months of age, and then declines gradually to adult levels at 36 months of age. Because similar patterns of developmental changes in the receptor density of ␣ 2 -and ␤-adrenergic, D 2 -dopaminergic, 5HT 2 -serotoninergic, and M 1 -muscarinic receptors are observed in the cerebral cortex, these authors postulate that synaptic circuitry formation may be orchestrated by a common diffusible factor or a synchronous activation by a common gene.
The developmental pattern of each GABA A receptor subunit is complex and differs from region to region or neuron to neuron, which ensures the functional heterogeneity of GABA input. Nonetheless, it has been reported consistently that, in general, ␣ 2 -subunit expression is very high before birth to shortly after birth, and decreases gradually toward adult levels, whereas ␣ 1 expression is minimal before birth and then gradually increases after birth until adulthood (213-216, 241). In fact, it appears that GABA A receptors containing ␣ 1 -subunits gradually replace GABA A receptors containing the ␣ 2 -subunit during postnatal maturation in the rat, monkey, and human brain, and that the increase in the ␣ 1 -subunit is an indication of brain maturation, i.e., the onset of synaptic GABA inhibition, whereas ␤-subunits do not generally undergo developmental changes (213, 214, 241 It is probable, therefore, that developmental changes in the GABA A subunit composition in neuronal cells may occur before the onset of puberty. Analysis of the literature provides support for the hypothesis that GABA disinhibition of LHRH neurons through GABA A receptors at the onset of puberty in female monkeys (217) is due to changes in GABA A receptor subunit composition. For example, the discrepancy that some LHRH neurons in adult rats express the ␤ 3 -, but not ␣ 1 -or ␤ 2 -, GABA A subunits (218), whereas in peripubertal female rats a subset of LHRH neurons express ␣ 1 -, ␣ 2 -, ␤ 3 -, and ␥ 2 -, but not ␥ 1 -subunits (219), may be due to technical differences in the two studies, but it may also be due to developmental changes in subunit composition. In fact, a recent report by Herbison and colleagues (243) using single cell RT-PCR suggest that GABA A subunit composition in LHRH neurons located in the POA and medial septum of sexually immature mice at neonatal and juvenile ages is more heterogeneous than that in adults, and it becomes homogeneous when the mice mature, supporting this notion. Interestingly, the same authors have reported that sensitivity to GABA in LHRH neurons of juvenile mice is lower than that in adult mice and that the pattern of the dose-response curve to GABA in prepubertal LHRH neurons is more heterogeneous than that in adult LHRH neurons (243). At this time, we have little knowledge of developmental changes in the GABA A subunit composition of LHRH neurons in nonhuman primates.
d. Direct and indirect control of LHRH neurons by GABA.
GABA input can change activity of LHRH neurons directly. Perikarya of LHRH neurons are innervated by GADcontaining axons (presumably GABA neurons) in rats (244 -246), but not in monkeys (247). LHRH neurons in the POA of adult rats and GT-1 neurons express the GABA A ␤ 2 /␤ 3 -subunit (218, 248), and the ␣ 1 -subunit colocalizes with LHRH in GT-1 neurons (248, 249). Although abundant distribution of ␣ 2 -subunit mRNA in the rat POA has been reported (250), only a small number of LHRH neurons express the ␣ 2 -subunit (219). El-Etr et al. (248) report that the GABA A ␥ 2 -subunit mRNA is not expressed in GT-1 cells. It is, however, possible that the negative data are in part due to technical problems. In fact, a recent study with single cell RT-PCR indicates that GABA A receptors on the LHRH membrane in adult mice are assembled from ␣ 1 -, ␣ 3 -, ␣ 5 -, ␤ 1 -, and ␥ 2 -subunits (243) and 100% of adult mouse LHRH neurons respond to GABA (243).
In primates, direct innervation of LHRH neurons by GABA neurons has not been found (247), although inhibitory synapses on LHRH perikarya, their phenotype yet to be determined, have been reported recently (150). However, GABA inhibition of LHRH neurons could be through glutamatergic neurons, since there is a reciprocal innervation between GABAergic and glutamatergic neurons in monkeys e. Role of GABA in LHRH release. The role of GABA in the control of LHRH release appears to be both inhibitory and stimulatory. For example, some early studies indicate that systemic administration or intracerebroventricular infusion of GABA, and application of GABA onto hypothalamic explants, stimulates LHRH and LH release (254 -256), while others show inhibitory or biphasic/triphasic effects (257-261).
Recent studies using GT-1 cells (249, 262, 263) and LHRH neurons from the mouse olfactory pit (264) suggest that GABA induces excitatory effects on LHRH release, intracellular Ca 2ϩ oscillations, and membrane potentials, although the study by Martinez de la Escalera et al. (262) demonstrates that an initial stimulatory effect on LHRH release is followed by prolonged inhibition.
It is possible that GABA is an inhibitory neurotransmitter through GABA A receptors, whereas it is a stimulatory neurotransmitter through GABA B receptors for pulsatile LHRH/LH release in adult female animals. GABA release in the medial preoptic area (MPOA) is pulsatile, and a reduction of GABA release precedes an increase in LH release in OVX rats (265, 266). Direct infusion of GABA into the POA suppresses LH release in rats and sheep (267-270), and GABA and the GABA A agonist, muscimol, inhibit LH pulses when injected into the third ventricle or the MPOA in rats (257, 271). Similarly, muscimol suppresses, and the GABA A antagonist bicuculline stimulates, the pulse frequency, but not the pulse amplitude, of LHRH pulse-generator activity, as determined by multiunit activity recording in the hypothalamus of OVX female rats (272). In contrast, infusion of baclofen, a GABA B agonist, into the arcuate-ventromedial nucleus stimulates LH pulses in castrated rams during the nonbreeding season (268, 273, 274). There are, however, reports indicating that GABA B receptors are inhibitory for basal LHRH release (258, 260, 261). In addition, the GABA B agonist baclofen iontophoretically applied to adult LHRH neurons in guinea pigs causes immediate hyperpolarization via opening of potassium channels (274a), indicating that the direct, GABA B -mediated action of GABA in these cells is inhibitory.
GABA is also an important inhibitory neurotransmitter before the preovulatory LH surge, and in the positive feedback action of ovarian steroids in females. GABA release as well as GAD67 and GAD65 mRNA levels in the MPOA decrease before the initiation of an estrogen-induced LH surge in OVX female rats and ewes (265, 266, 269, 275-278) and before the LH surge in female rats (269, 270). The GABA turnover rate also decreases before the estrogen-induced LH surge (276). GABA or muscimol infusion into the third ventricle or MPOA blocks the preovulatory LH surge in female rats and reduces the size of the estrogen-induced LH surge in OVX rats (276, 279 -281), while both intraventricular and intravenous infusions of bicuculline advance the timing of the LH surge in estrogen-primed OVX rats and proestrous rats (271, 282). There is a report, however, that GABA B , not GABA A , receptors mediate inhibitory action of GABA during the LHRH surge (274b).
In males, GABA neurons are involved in the negative feedback effects of testosterone. The GABA turnover rate as well as GAD67 and GAD65 mRNA levels in the MPOA decrease after castration concomitant with an increase in LH release, whereas testosterone administration prevents these changes in adult male rats (283, 284). Moreover, the GABA turnover rate in the MPOA decreases with an increase in LH release after implantation of the androgen receptor antagonist, hydroxyflutamide, into the rostral portion of the MPOA (285).
The conflicting stimulatory and inhibitory roles of GABA in LHRH release may be, in part, explained by the following hypotheses. First, GABA action may differ depending on the receptor subtype. In some studies the receptor subtype is not examined. Second, since GABA effects on LHRH neurons may occur not only directly, but also indirectly through interneurons, results may depend on alterations in the population and/or sensitivity of interneurons, differences in the location of GABA infusion in in vivo studies, and the loss of input from other brain areas in in vitro hypothalamic explant studies. For instance, in in vitro studies Nikolarakis et al. (259) suggest that GABA is inhibitory at LHRH neuroterminals, but stimulatory at LHRH perikarya through inhibitory opioid neurons. GABA input to LHRH neurons in the monkey hypothalamus appears to occur indirectly through glutamate neurons (247, 286).
Third, GABA A receptor properties may change during maturation, such that GABA is excitatory when LHRHsecreting cells are immature, whereas GABA is inhibitory when LHRH neurons become mature. GABA is stimulatory in immature neurons, such as GT-1 cells and cultured LHRH cells from embryonic mice (249, 263, 264). Similar developmental switches of GABA action have been shown not only in the hypothalamus (287, 288), but also in the spinal cord, hippocampus, cerebellum, cortex, and olfactory bulb (see Refs. 289 and 290). So far, two possible mechanisms of developmental changes in GABA A receptor properties have been shown. 1) Changes in the subunit composition of GABA A receptors occur during maturation of the brain (215, 241, 291) or under different physiological conditions (292), whereby the response to GABA varies, as discussed in a previous section. A recent report, however, indicates that although the changes in the subunit composition of GABA A receptors in mouse LHRH neurons occurs between the juvenile and adult stages, GABA input to LHRH neurons is excitatory regardless of the age of mice when tested using pipettes filled with a high chloride solution (243). 2) Changes in the response to GABA could be explained by chloride homeostasis during maturation (290) or some physiological conditions, such as diurnal rhythmicity (293). There is a differential chloride gradient across the neuronal membrane, which is reversed between the immature state and the mature state (294 -296). A recent report further suggests that the
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NEUROBIOLOGY OF PUBERTYneuronal Cl Ϫ -extruding K ϩ /Cl Ϫ cotransporter, KCC2, responsible for hyperpolarizing postsynaptic inhibition (297), undergoes developmental changes when hippocampal pyramidal neurons developmentally switch GABA A -mediated responses from the depolarizing state to the hyperpolarizing state (298).
Fourth, interaction with glutamatergic input and/or receptors due to physiological changes, including neuronal maturation, may alter receptor sensitivity to GABA or the relative importance of the inhibitory GABAergic input to the stimulatory glutamatergic input. This was clearly shown in the hippocampus (290) as well as in the POA-hypothalamus (306, 307). Fifth, GABA receptor subunit composition can be altered by the presence of steroid hormones. For example, estrogen injection in OVX rats altered GABA A receptor subunit composition (250, 299).
GABA neurons or GABA A receptors seem to mediate progesterone action as follows: 1) Progesterone receptorcontaining neurons in the monkey and rat hypothalamus are GABA neurons (246, 300); and 2) GABA A receptors contain steroid recognition sites (301), i.e., neurosteroids, which include some progesterone metabolites and derivatives, exert their action through GABA A receptors located on the cell membrane (301). Recently, Herbison et al. (302) demonstrated that allopregnanolone, a neurosteroid derived from circulating progesterone, directly exerts a facilitatory action on GABA A receptor-chloride channels in LHRH neurons. GABA neurons also appear to mediate estrogen action. In rats, estrogen-receptive cells in the arcuate nucleus are also GABA neurons (245), and estrogen is necessary for an increase in the number of progesterone receptors in immunostained GABA neurons of OVX monkeys (246, 300). Moreover, the fact that a decline in GABA levels in the MPOA occurs before the estrogen-induced LH surge in rats and sheep (275, 303), while an elevation of GABA levels in the MPOA occurs during the negative feedback action of estrogen in sheep (275), further supports the possible role of GABA neurons in estrogen action. Conversely, estrogen priming in OVX rats increases GABA A receptor ␣ 2 -, and ␥ 1 -, but not ␤ 3 -, subunit mRNAs in the POA and bed nucleus of the stria terminalis (250).
f. Role of GABA in puberty. There are reports that GABA is stimulatory on LH release in male and female rats during the juvenile stage, whereas GABA is inhibitory around the age of puberty (304 -307). Mitsushima and Kimura (308) report that neither bicuculline nor muscimol causes any significant effect on LH release in sexually immature male rats, whereas bicuculline stimulates and muscimol inhibits LH release in pubertal male rats. In contrast, our studies in nonhuman primates using push-pull perfusion suggest that the LHRH neuronal system is tonically inhibited by GABA neurons before the onset of puberty (Fig. 2) . First, GABA levels in the S-ME in prepubertal rhesus monkeys are much higher than in midpubertal monkeys (217, 240). Second, bicuculline, a GABA A antagonist, stimulates LHRH release in prepubertal monkeys by removing endogenous GABA inhibition, whereas exogenous GABA is not effective in suppressing LHRH release until after the onset of puberty, when endogenous GABAergic tone is reduced (217). Third, infusion of antisense oligodeoxynucleotides for GAD67 and GAD65 mRNAs into the S-ME of prepubertal monkeys results in a dramatic increase in LHRH release (309, 310), presumably due to the reduction in GABA synthesis and subsequent release (240, 309). Finally, pulsatile infusion of bicuculline into the third ventricle of prepubertal monkeys results in precocious menarche, which occurs 6 -8 weeks after the initiation of bicuculline infusion, and in precocious first ovulation, which occurs by 30 months, the age of menarche in control females (311) . However, since the interval between menarche and first ovulation is not shortened by bicuculline infusion, additional mechanisms, such as the establishment of the stimulatory neuronal system for pulsatile LHRH release, are necessary for the pubertal transition in female primates. Nonetheless, disinhibition of LHRH neurons from GABA appears to be critical for the onset of puberty in primates (Table 1) .
g. The role of GABA in sexual differentiation in the brain.
Sexual differentiation of the rodent brain is dependent upon exposure to estrogen or testosterone during the perinatal critical period, beginning in late gestation and ending early in neonatal life (312, 313) . Sexual dimorphism of the brain, including the male dominant sexually dimorphic nuclei (314, 315) , and the female dominant anterior ventral periventricular nucleus [or medial preoptic nucleus (316 -318) ], has been extensively described. According to a series of studies by McCarthy, Selmanoff, and colleagues (226, 227, 319), GABA neurons appear to mediate steroid action on the sexual differentiation of the brain during the perinatal period. The GABA turnover rate in the medial preoptic nucleus in the MPOA and ventromedial nucleus of the hypothalamus (VMH) in male rats is 2-fold higher than in female rats (319) , and GAD67 and GAD65 mRNA levels in the MPOA and VMH in males are higher than in females on P1, but not on P15 (226, 227). Neonatal castration of male rats results in the female type of GAD mRNA responses, whereas neonatal treatment of female rats with testosterone results in the male type of GAD mRNA responses (227). Further, a higher level of GABA in the VMH and arcuate nucleus in males than in females is observed only during the first few days of life (226), and this dimorphism is lost as GABA levels increase developmentally in both males and females (320) . A similar sex difference in GABA concentrations in the MPOA of P10 rats has also been reported by others (225). Since GABA has a potent growth factor-like property for neuronal survival and migration, growth cone guidance, and neurite branching (224, [321] [322] [323] [324] [325] [326] [327] [328] , and since GABA is excitatory in the neonatal period, McCarthy and colleagues (328) propose the hypothesis that a rise in GABA release induced by testosterone during the critical period of sexual differentiation permanently alters the structure and function of the POA and hypothalamus.
h. GABA and human diseases associated with puberty. There is evidence indicating that GABA neurons may be responsible for diseases associated with puberty. First, it has been documented that the onset of schizophrenia often occurs between late puberty and early young adulthood (7) . A significant decrease in GAT-1 immunoreactivity on axonal
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TERASAWA AND FERNANDEZ Vol. 22, No. 1 terminals of a subset of GABA neurons that innervate pyramidal cells in the frontal cortex is observed in patients with schizophrenia when compared with normal human subjects (329) . Second, the new onset of epileptic seizures tends to occur early in life and during the adolescent period (10) . Precocious puberty is often associated with epilepsy in children (8, 9) . Furthermore, treatment with sodium valproic acid, a GABA agonist-the mechanism of action has yet to be determined-delays the timing of puberty in children with seizure disorders (330, 331) and in genetically epilepsy-prone mice (332) . It is possible that the pubertal increase in gonadal steroids may sensitize neurocircuits involved in epileptic seizures, but it is also possible that there is a common mechanism of developmental deficiency, i.e., weakened GABA inhibition in the LHRH neuronal system resulting in precocious puberty and weakened GABAergic inhibition in the brain at the pubertal age resulting in epilepsy (333) . Recently, Bourguignon and colleagues (334) treated an 11-month-old child, who exhibited severe epileptic seizures and precocious puberty, with loreclezole and vigabatrin, GABA agonists. At an earlier stage, traditional treatment for epilepsy with phenobarbital was not effective in this patient. However, treatment with loreclezole followed by vigabatrin not only caused all signs of precocious puberty to regress, but also settled seizure attacks. Finally, a study indicates that treatment with the GABA agonist valproate results in a high rate of polycystic ovaries with elevated serum testosterone concentrations among women with epilepsy, especially if the patients start to receive the valproate treatment before the age of 20 yr (335) . Taking into consideration the recent view that polycystic ovarian syndrome originates during the pubertal stage (11, 12) , it is possible that an irregularity of the normal control of pulsatile LHRH release by the GABA neurotransmitter system during puberty and/or failure of opioid inhibition during the postpubertal period may be a cause of the polycystic ovarian syndrome, although this is highly speculative.
Other inhibitory neuropeptides and neurotransmitters.
The neuropeptides, such as vasoactive intestinal peptide (VIP), CRH, and melatonin, are inhibitory to neuronal activity (336, 337) and could be potential inhibitory neurotransmitters before the onset of puberty. However, to date, the role of hypothalamic VIP in puberty has not been systematically studied, and available evidence indicates that changes in CRH are not likely to play a major role in determining the timing of puberty. ␤-END, ACTH, and cortisol levels in response to CRH in children and adult humans are independent from age and sexual maturity (338, 339) , and there is no evidence for direct inhibitory effects of CRH on LHRH release. Therefore, in this section we will only discuss the role of melatonin in puberty.
a. Melatonin. Melatonin has been suggested as an inhibitory neurotransmitter for puberty. This is based on the observations that 1) some human patients with pineal tumors exhibit precocious puberty (340); 2) circulating melatonin concentration is elevated in early childhood, declines during late childhood, and remains stable from the early pubertal period to adulthood in humans and monkeys (341-345); 3) melatonin, which is elevated during the nighttime, is inhibitory for the timing of puberty in hamsters and sheep (346, 347); and 4) circadian melatonin rhythm in blind men differs from normal men (348) , and timing of puberty in blind boys is delayed (349) , although blind girls with no light perception have earlier onset of menarche than normal girls (350, 351) .
However, pineal melatonin is probably not involved in the mechanism of gonadotropin suppression during prepuberty in primates (Table 1) . Pineal tumors are often accompanied by lesions in the brain that may be responsible for precocious puberty (352) (353) (354) (355) , and the tumor itself may release gonadotropic hormones or substances stimulatory to gonadotropin secretion (356). Further, studies of male patients with LHRH deficiency compared with normal males suggest that a decrease in circulating melatonin before puberty appears to be due to a slight increase in circulating LH which stimulates gonadal steroids (357, 358). Similarly, in female rhesus monkeys, a pubertal increase in LH precedes a decrease in nocturnal melatonin levels by 2 months, and treatment with melatonin for 30 days does not delay pubertal increases in estradiol, insulin-like growth factor I (IGF-I), and perineal coloration (359). Finally and most importantly, pinealectomy during the neonatal period in castrated male rhesus monkeys (360) and at 20 -23 months of age in OVX female rhesus monkeys (94) does not alter the pattern of developmental changes in gonadotropin secretion.
Nonetheless, a series of studies by Bellestella and colleagues (see Ref. 361) in blind humans indicate that light signals appear to be important for secretion of LH, FSH, PRL, GH, and TSH. Considering the fact that the nocturnal increase in LH release becomes prominent during the pubertal period in female primates (73, 74), and that in fact this has been used as one of the earliest signs of puberty in female rhesus monkeys in our laboratory (18, 72) , circadian rhythms from light signals to the hypothalamus, which may or may not be mediated by melatonin, appear to be important for the mechanism of the onset of puberty. Additional research in this area is urgently needed.
B. Stimulatory neurotransmitters
1. The excitatory amino acid glutamate. Glutamate, l-glutamic acid, is the major excitatory amino acid neurotransmitter in the hypothalamus (362, 363), and LHRH neurons receive direct glutamatergic innervations (247). The role of glutamate in the control of LHRH release has been reviewed extensively (281, 364, 365). Thus, in this article we will focus on the changes in the glutamatergic system during development and the role of glutamate in the mechanism of puberty.
Glutamate is the endogenous ligand for two major excitatory amino acid receptors: 1) ionotropic receptors coupled to ion channels, which are further divided into NMDA, kainite, and ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor subtypes; and 2) metabotropic receptors coupled to G proteins. All these receptors are present in the hypothalamus (366, 367), and activation of all three ionotropic receptors is stimulatory to LHRH/LH secretion in adult animals (see Ref. 365 ).
a. Developmental changes in glutamate synthesis and release.
Glutamate synthesis: The availability of releasable glutamate
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NEUROBIOLOGY OF PUBERTYfrom neuroterminals is essential for stimulation of LHRH release and hence for the control of the onset of puberty. The activity of the enzyme for glutamate synthesis from glutamine, namely glutaminase, is greater after puberty (P50) than before puberty (P15), reflecting an increased glutamatergic input to the LHRH neurons after puberty (368). Bourguignon and colleagues have shown that application of glutamine, a precursor for glutamate synthesis, to hypothalamic explants from P15 and P50 male rats results in LHRH release in a dose-dependent manner, whereas application of the glutaminase inhibitor, 6-diazo-5-oxo-l-norleucine (DON), blocks glutamine-induced LHRH release and veratridineinduced LHRH increase, but not glutamate-induced LHRH release (368). Interestingly, inhibition of glutamine-induced and veratridine-induced LHRH increase requires higher concentrations of DON in P50 than P15 hypothalami, indicating that increased activity of glutamate biosynthesis from glutamine occurs at or shortly after the onset of puberty (368). However, this increased glutaminase activity appears to be due to an increase in posttranscriptional changes in glutaminase mRNA, since mRNA levels increase after birth and reach a maximum by the second week, well before puberty (369), and since glutaminase mRNA levels do not change during pubertal development in the rat hypothalamus (228).
The relationship between glutamate synthesis and the onset of puberty in primates has not been studied. Glutamate release: Since endogenous glutamate exists as four different pools-a transmitter pool, a metabolic pool, a glial pool, and a GABA precursor pool (370)-the role of glutamate in puberty is complex. However, because no literature is available on the developmental context of different pools, we will describe glutamate concentrations as a single entity. Glutamate concentrations in the rat hypothalamus increase with postnatal age (225), reaching a maximum after the onset of puberty (229), and in the rat cortex glutamate levels also continue to increase until adulthood (371). More recent studies indicate that glutamate concentrations in the POA/MBH and release from POA/MBH explants increase between P16 and P30 in female rats (372, 373). In female rhesus monkeys, glutamate release measured by push-pull perfusion in the S-ME is very low during the prepubertal period, increases dramatically during the early pubertal period, and remains high during the midpubertal period, although midpubertal levels decline slightly from early pubertal levels (240). The pubertal elevation of glutamate may occur promptly after GABA reduction before the onset of puberty, since glutamate release increases several hours after the initiation of treatment with antisense GAD67 in prepubertal monkeys, which results in the reduction of GABA release within 3 h of the initiation of the antisense treatment (240).
b. Role of glutamate in puberty.
Glutamate is profoundly involved in pulsatile LHRH release in vivo and in vitro through NMDA and kainate receptors. NMDA stimulates release of LH and LHRH in adult rats and monkeys in vivo (Refs. 374 -376 and 384 -386 and Fig. 2 Similarly, glutamate, NMDA, and kainate all stimulate LHRH/LH release in sexually immature monkeys (384 -386), rats (380, 387, 388), sheep (389), and fetal sheep (390) in vitro and in vivo. Moreover, stimulation of NMDA receptors results in precocious puberty in rats and monkeys (132, 133), whereas administration of the NMDA receptor blockers, MK-801 or 2-amino-5-phosphonovaleric acid (AP-5), delays the timing of puberty in rats (382, 391-393). In contrast, the non-NMDA receptor antagonist, 6,7-dinitro-quinoxaline-2,3-dione (DNQX), fails to change the timing of puberty (364). The excitatory action of glutamate on LHRH release may occur not only through NMDA receptors, but also through metabotropic receptors. Therefore, the developmental changes in NMDA and AMPA receptors are integrated parts of the mechanism of the mechanism of puberty (see below).
c. Sensitivity changes in LHRH response to glutamate during puberty. Sensitivity to glutamate stimulation temporarily increases during the pubertal period in rats. First, NMDA sensitivity in male rat hypothalamic explants increases from prepubertal levels between P15 and P25, and then decreases at P50 to levels similar to the prepubertal levels (136). Likewise, sensitivity to MK-801 increases between P15 and P25 rats, progressively decreases beginning at P30, and returns to prepubertal levels by P50 (136). Paradoxically, low doses of the NMDA receptor blocker MK-801 (0.1-10 pm) are stimulatory, rather than inhibitory, to LHRH release at P15, but not at P25. However, higher doses of MK-801 (10 -100 m) at P15 suppress LHRH release, and only the highest dose (100 m) is effective in suppressing LHRH release at P25 (381). Based on these and other data, Bourguignon and colleagues (381) propose that a component of glutamatergic input through NMDA receptors is inhibitory to LHRH release in juvenile rats, and it becomes gradually stimulatory to LHRH release as animals grow. As puberty comes to a close, the disappearance of an inhibitory NMDA system enhances a stimulatory NMDA system, thereby resulting in the increase in NMDA-induced LHRH release. Second, immunostaining for c-fos in the arcuate nucleus after NMDA stimulation is greatest between P15 and P20 and is lower both before and after this period (394). Third, the effectiveness of stimulatory effects of NMDA and kainate on LHRH release from POA/ MBH explants of female rats is greater at P30 than at P16 (395, 396), and NMDA enhances the steroid-induced LHRH release from POA/MBH explants at P30, but not at P16 in female rats (395).
In rhesus monkeys as well, sensitivity to glutamatergic stimulation increases at puberty. For example, 1) infusion of NMDA into the S-ME at 10 m-100 m stimulates LHRH release in pubertal monkeys, whereas only 100 m NMDA results in LHRH release in prepubertal monkeys (397); and 2) intravenous injection of NMDA at 10 mg/kg results in d. Developmental changes in NMDA receptors. The NMDA receptor subunit NR1 is an essential component in the formation of the functional NMDA receptor, which exists as a heteromeric complex consisting of NR1 plus one or more subunits of the NR2 family (399, 400). NR1 immunoreactivity has been reported in most of the hypothalamic nuclei of the rat (for review see Ref. 365), and both NR1 mRNA and protein increase during development. Two phases of developmental increases in NR1 mRNA levels in the POA and the hypothalamus of rodents have been described. The first prominent increase occurs between E18 and P10 during which NR1 mRNA levels in the POA/anterior hypothalamus increase approximately 5-fold in both male and female rats (401, 402). In guinea pigs, as well, MK-801 binding increases from midgestation to late gestation (403). Similarly, immunoreactivity of NMDA-R1 protein increases from P0 through P10 in both male and female rats (401). The second phase of a slight, but significant, increase in NR1 mRNA levels occurs between P10 and P25, approximately 10 days before the onset of puberty in rats (404 -406). Interestingly, there are no further changes in NR1 mRNA levels around the onset of puberty (404, 406), although Nyberg et al. (405) report that NR1 mRNA increases on the first proestrus before first ovulation. Absence of changes in NR1 mRNA levels and NMDA receptor binding after steroid hormone treatments in adult OVX rats has also been reported (364).
In light of the physiological data on the role of NMDA receptors in puberty, colocalization of NMDA receptors in LHRH neurons has been studied extensively. No colocalization of NR1 in LHRH neurons in rats at P0 -P14 (401) has been reported, and less than 5% of LHRH neurons contain NR1 mRNA in the POA/hypothalamus of adult rats and hamsters (407-409). Interestingly, the percentage of LHRH neurons that are double-labeled with NR1 increases from 0% to 5% between prepuberty and postpuberty (404). It is possible, however, that the low percentage of NR1 mRNA containing LHRH neurons may be due to current technical limitations, since high levels of mRNA are required for in situ hybridization studies and clean, highly specific antibodies for NMDA subunits are not available.
Since the combination of different subunits appears to yield differential receptor dynamics, changes in NR2 subunit expression could result in changes in responsiveness to glutamatergic stimulation. For example, it has been reported that LHRH neurons are insensitive to glutamate during the embryonic period (264), but glutamate acting through NMDA receptors is inhibitory to LHRH release during early postnatal development (381), whereas it stimulates the release of LHRH as animals mature (307). Based on an experiment with antisense oligonucleotides for NR2a and NR2c mRNAs in male rat hypothalamic explants, Bourguignon and colleagues (307) further suggest that changes in NMDA receptor subunit composition in relation to LHRH release occur as animals mature, i.e., the NR2c subunit is involved in the inhibitory function of NMDA receptors on LHRH release at P15, but this inhibitory function of NR2c no longer exists at P25. In contrast, the NR2a subunit is involved in the stimulatory function of NMDA receptors on pulsatile LHRH release at both P15 and P25. NR2a levels in male rats increase from undetectable levels between E18 and P15, first becoming detectable at P0, whereas in females NR2a mRNA levels are not detectable until P5 and disappear after P10 (401). NR2b mRNA levels are lower at E18 and P0 than at P5 through P15 in both males and females (401). Eyigor and Jennes (410) report that NR2a subunit mRNA levels colocalizing in LHRH neurons do not change with age between P20 and P50 in female rats. Developmental changes in subunit composition are very important for understanding the role of glutamate. However, since neither changes in mRNA nor receptor numbers alone reflect the state of the receptor function, comprehensive analysis is necessary before conclusions can be made.
e. Developmental changes in non-NMDA receptors. AMPA receptor subunit GluR1 mRNA levels in the rat POA, measured by quantitative RT-PCR, increase transiently on P20, but the levels at all other ages are comparable, and no change in GluR1 subunit mRNA is seen in the MBH at any time (406). AMPA binding also increases in the hypothalamus of rats from P20 through P33 (1 day before vaginal opening), followed by a return to P20 levels by P35 (406). Sex differences in non-NMDA receptors in neonatal rats have also been reported (411). Thus, it is possible that maturational changes in AMPA receptors are important for the pubertal transition.
The concentration of kainate receptor (KA2) mRNA and the number of LHRH neurons expressing KA2 mRNA increase progressively between P20 and P40, and especially the morning levels of KA2 mRNA are higher than the afternoon levels at P30 and P40 than at P20 in female rats (410). Because first ovulation usually occurs around P35 in female rats, these authors propose that kainate receptors may be involved in the mechanism of the onset of puberty. Further, these authors postulate that a direct signal of excitatory glutamate to LHRH neurons is primarily mediated through kainate receptors, and glutamate signals through NMDA receptors may be mediated by interneurons, based on the fact that a large number of LHRH neurons express KA2 mRNA, but not NR1 mRNA (410). Kainate binding, however, does not change in the hypothalamus during the pubertal transition time (406). Nonetheless, the facts that ovarian steroids increase GluR1 subunit levels (412), that kainate injection advances the onset of puberty by only 1 day, and that DNQX, a non-NMDA receptor blocker, fails to alter the timing of puberty (364) suggest that high GluR1 mRNA levels and AMPA binding property, as well as high KA2 mRNA levels around the age of puberty, may be a consequence of the pubertal increase in steroid hormones, rather than a cause of puberty. At the time of this writing, there are insufficient data on the glutamate receptor subtypes to determine which ones are associated with puberty or to support the hypothesis that non-NMDA receptors play a major role in the onset of puberty. Nonetheless, glutamate neurons are very important for the mechanism of the onset of puberty in many mammalian species (Table 2) .
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The catecholamine norepinephrine (NE).
a. Role of NE in puberty. Among many neurotransmitters and neuropeptides involved in LHRH release, adrenergic neurons in rodents have been most intensively implicated in the control of pulsatile LHRH and LH release and in the ovarian steroid-stimulated gonadotropin surge, and several excellent reviews are available (155, 413-417). Adrenergic receptors are present as ␣ 1 -, ␣ 2 -, ␤ 1 -, and ␤ 2 -receptors. Each receptor type has specific agonists and antagonists, and ␣-receptors often have opposing effects to ␤-receptors. In primates, ␣-adrenergic input, particularly ␣ 1 -, but not ␣ 2 -and ␤-receptors, modulates pulsatile LH and LHRH release (418 -423). Our studies further support a facilitatory role of NE in pulsatile LHRH release in the OVX monkey: administration of the ␣ 1 -adrenergic blocker, prazosin, suppresses LHRH release in the median eminence (421, 422, 424); direct infusion of the ␣ 1 -adrenergic stimulant, methoxamine, or NE itself, facilitates LHRH release (423); and NE release from the S-ME is pulsatile and is synchronous with pulsatile LHRH release (424).
The stimulatory role of catecholamines in puberty was first postulated by Weiner and Ganong (425), based on the observation that treatment with reserpine, a monoamine syn- 2. NPY release in portal circulation in rats or in the S-ME in female monkeys increases in association with puberty.
511, 514
3. Intraventricular infusion of an NPY antiserum delays the timing of puberty in rats. 541 4. Infusion of an antiserum to NPY into the S-ME suppresses LHRH release in pubertal monkeys. 514 5. Acute, intraventricular infusion of NPY advances the timing of puberty in rats and chicks. 541, 542 6. Infusion of NPY into the S-ME stimulates LHRH release in pubertal, but not prepubertal monkeys. , which interferes with dopamine-␤-hydroxylase, suppresses the postcastration-induced LH release in rats at all ages examined between P7 and P28 (428), whereas inhibition of NE synthesis with ␣-methyl-paratyrosine (␣-MPT), which interferes with conversion of l-dopa to the NE precursor dopamine, slightly suppresses the postcastration-induced LH release only in juvenile rats (428). Moreover, diethyldithiocarbamic acid, a dopamine-␤-hydroxylase inhibitor, prevents the progesterone-induced LH surge as well as LHRH mRNA expression in pubertal, OVX, estrogenprimed rats (429). These data indicate that NE is an important neurotransmitter for the pubertal increase in LH/LHRH release. Nonetheless, puberty induced by social cues is not regulated by catecholamines (430).
We have examined the role of the ␣ 1 -adrenergic neuronal system in puberty in female rhesus monkeys (431, 432). Prepubertal monkeys exhibit the greatest LHRH increase in response to methoxamine, followed by a moderate increase in early pubertal monkeys, with the lowest LHRH increase in midpubertal monkeys when measured by push-pull perfusion in the S-ME (431). Because NE levels in the S-ME are low in prepubertal and early pubertal monkeys and increase 6-fold in midpubertal monkeys, a larger responsiveness of the LHRH neuronal system to methoxamine stimulation in younger groups is probably due to the absence of high levels of endogenous NE, a situation similar to denervation hypersensitivity (431). Therefore, increase in NE stimulation in early pubertal monkeys may contribute to, rather than be critical for, the increase in LHRH release during pubertal development (Fig. 2) . In support of this view, while transplantation of adrenal chromaffin cells, which contain high amounts of catecholamines and neuropeptide Y (NPY), into the third ventricle of three prepubertal monkeys (12-13 months of age) does not alter the timing of menarche, it significantly advances the age of first ovulation (433). In fact, in two of the three monkeys, first ovulation occurred at 30 -32 months of age. Since first ovulation at 30 -32 months of age was exceptionally early compared with our colony monkeys, we concluded that catecholaminergic neurons as well as other factors in transplants contribute to the facilitation of the onset of puberty (433). However, the fact that first ovulation did not occur until 17-19 months after chromaffin cell transplantation suggests that supplying the stimulatory neurons to the hypothalamus may not be sufficient to result in pubertal activation of LHRH neurons. A GABA mechanism restraining LHRH release is predominant in the immature hypothalamus, and this inhibitory mechanism may need to be removed before a facilitatory mechanism is activated.
In contrast to the prepubertal and peripubertal animal, NE may be inhibitory to LHRH release during embryonic development. Both phenylephrine and clonidine, ␣ 1 -and ␣ 2 -adrenergic agonists, respectively, suppress LHRH release from primary hypothalamic cell cultures from E16 rat embryos cultured for 12 days (434, 435). On the other hand, prazosin and rauwolscine, ␣ 1 -and ␣ 2 -adrenergic antagonists, respectively, enhance LHRH release. Treatment with the tyrosine hydroxylase (TH) inhibitor, ␣-MPT, resulted in increased LHRH release. However, since inhibition of TH also interferes with dopamine synthesis, the authors tested the effects of SCH23390 or sulpiride, D 1 -and D 2 -dopaminergic antagonists, on LHRH release, respectively. Based on the negative results with dopaminergic antagonists, the authors conclude that LHRH release in fetal hypothalamic cell cultures is under the inhibitory control of intrahypothalamic NE. Therefore, a developmental shift of NE action on LHRH release may occur. In support of this notion LHRH release in response to NE does not occur from P9 rat hypothalamic explants, whereas NE stimulates LHRH release from P29 explants, similar to the adult pattern, and this change is steroid independent, because pretreatment with estrogen does not alter LHRH response to NE in either age group (436).
b. Developmental changes in NE neurons. Noradrenergic neurons in the locus coeruleus of rats are differentiated by E13 (437). Cell bodies in the A11-13 groups (NE neurons) become visible by fluorescent staining for catecholamines during the first week of life (438) . Fluorescence intensity as well as cell number of catecholamine-positive cells reaches a maximum between the second and third week after birth and then declines through week 5 when adult levels are attained (438) . However, this method measures both NE and dopamine. In contrast, NE levels in the brain of sheep are low during the embryonic period through P5, and the levels in the lateral, dorsomedial, and ventromedial hypothalamic areas then increase at P25 to P30 (439) .
Levels of NE in the hypothalamus and brain regions that project to the hypothalamus change from embryonic to adult stages of life. NE concentrations in rat diencephalon increase 9-fold from E15 to birth (440) . From P0 to P18, the period that corresponds to the development of noradrenergic innervation of the hypothalamus through the dorsal and ventral noradrenergic bundles, NE concentrations in the diencephalon further increase (440) . NE concentrations in the MPOA and hypothalamus then continue to increase to the adult level by no later than 5 to 6 weeks of age (428, [441] [442] [443] [444] [445] [446] [447] [448] [449] [450] . NE concentrations in the MPOA increase before the pubertal age in female rats, although a few researchers have noted shortterm decreases in NE concentrations at the time of puberty. The discrepancy may be due to differences in methods and sampling locations. Nonetheless, hypothalamic concentrations of NE in female rats with posterior hypothalamic lesions exhibiting precocious puberty and in control rats on the day of vaginal opening are higher than in prepubertal control rats (451) , and NE turnover rates in the MPOA increase when estrogen induces an LH surge in P15 female rats (452) , similar to those observed with the proestrous surge, indicating that NE may be involved in the first LHRH surge, and hence the onset of puberty in rats (453) .
Activity of NE-synthesizing enzymes also changes during the pubertal period. Dopamine-␤-hydroxylase activity in the MPOA and anterior MBH in female rats is highest at P15, decreases significantly between P20 and P35, increases
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NEUROBIOLOGY OF PUBERTYslightly again at P40, and continues to increase to adult levels that are similar to levels seen in P15 animals (456) . There is no decrease in dopamine-␤-hydroxylase activity in the posterior MBH and even a slight increase in day 30 and 35 animals, followed by a major increase after puberty to the level seen in adulthood (456) . In rhesus monkeys NE neurons originate from the ventricular zone of the pontine lateral recess of the fourth ventricle at E30 -E33, migrate into the locus coeruleus, and differentiate into the cytologically mature form at E50 -E70 (454) . However, the size of NE cell soma continues to increase until P60 (454) . NE levels in the cerebral cortex steadily increase from birth to 36 months of age, at which point adult levels are attained (236, 455) . Similarly, NE release in the S-ME is low in prepubertal monkeys (14 -18 months) and substantially increases between early pubertal and midpubertal ages (431).
c. Turnover rate. Because the turnover rate may better reflect neurotransmitter activity than the local concentration, several researchers have measured NE turnover rates in rats. NE turnover is frequently determined by 1) the ratios between NE and its metabolites such as homovanillic acid or 3-methoxy-4-hydroxy-phenolglycol; or 2) inhibiting the synthesis of NE with dopamine-␤-hydroxylase inhibitors and then measuring the levels of NE and its metabolites after a specified period of time. NE turnover rates in the MPOA and MBH increase from low levels at P15 to higher levels at P20, and very high levels at P30 -P35 or at first early proestrus, coinciding with the time of puberty in female rats (444, 447, 457, 458) . NE turnover rates in the hypothalamus then decline after P35-P40 or at first late proestrus (444, 457, 458) . Therefore, NE turnover rates appear to increase before the onset of puberty in rats.
Norepinephrine transporter (NET) is also likely involved in the NE turnover rate. Although the role of NET in control of LHRH release has been studied in adult monkeys (459, 460) , its role in puberty has not yet been established.
d. Adrenergic receptors.
The noradrenergic control of LHRH release may occur at the level of the adrenergic receptor. The number of ␣ 1 -adrenergic binding sites increases from P0 to P21 in cell membrane preparations from the male and female rat brain (456) . In contrast, binding levels of [ 3 H]prazosin, an ␣ 1 -adrenergic antagonist, in the MPOA and hypothalamus of female guinea pigs decrease from P0, reaching adult levels by P7 (448) . Since lesion of noradrenergic neurons with 6-hydroxydopamine results in increased [
3 H]prazosin binding in the MPOA and hypothalamus (23% and 35%, respectively), and the difference is due to an increase in receptor number rather than a change in receptor affinity (448) , these authors conclude that the developmental increase in noradrenergic neurons decreases ␣ 1 -adrenergic binding in the hypothalamus by a decrease in receptor number rather than a change in receptor affinity (448) .
e. Possible mechanism of NE action through prostaglandins. PGE 2 has been shown to mediate NE-induced LHRH release by an intra-and extracellular Ca 2ϩ -dependent (461, 462), but not calmodulin-and cAMP-dependent, mechanism (463) . Treatment with NE induces release of PGE 2 and LHRH in a dose-responsive manner. Moreover, treatment with estradiol results in an increase in sensitivity of both PGE 2 and LHRH response to NE. Since LHRH release from median eminence explants of female rats increases from P22 through P34 in response to PGE 2 , and since the LHRH response to PGE 2 stimulation is blocked by ovariectomy on P22, but implantation of an estradiol-containing capsule on P30 restores the LHRH response to PGE 2 , the stimulatory action of NE on LHRH release is mediated by an estradiol-sensitive PGE 2 mechanism, which is further accelerated as puberty progresses (464) .
Collectively, NE neurons are important for the mechanism of the onset of puberty in rodents, but they appear to play a secondary role in puberty in primates ( Table 2) .
The catecholamine dopamine. a. Role of dopamine in puberty.
Despite a large amount of literature on the importance of dopamine in the control of LHRH release (for reviews see Ref. 253 and 465), the role of dopamine in the onset of puberty has been less well studied. While NE neuroterminals do not form synapses on LHRH neurons (465), dopamine neuroterminals do (253), suggesting that dopamine may play a role in the mechanism of puberty. For example, chronic treatment with pergolide, a dopamine D 1 /D 2 receptor agonist, advances the age of vaginal opening in rats (466) , but implantation of pimozide, a dopamine antagonist, in the MPOA in female rats also results in a precocious puberty (467, 468 ). An extensive study with selective lesions of dopamine and NE neurons using neurotoxic agents further indicates that the role of catecholamines in puberty is complex (427). Depletion of dopamine by intracisternal injection of 6-hydroxydopamine with desipramine, which spares NE neurons, on P31, results in delayed vaginal opening compared with the control as well as 6-hydroxydopamine alone, and similarly intraventricular treatment with 6-hydroxydopamine and desipramine on P30 decreases LH release induced by PMSG injection, suggesting a stimulatory role of extrahypothalamic dopamine in the mechanism of puberty (427). However, intravenous injection of 6-hydroxydopamine with desipramine on P30 into PMSGtreated rats results in an increase in LH release as well as LHRH release. Because 6-hydroxydopamine, when given intravenously, can only reach the median eminence, which is outside of the blood brain barrier, these results indicate that depletion of dopamine in the median eminence disinhibits LHRH release (427). Therefore, dopamine may have both stimulatory and inhibitory actions on puberty and LHRH release, as has been shown in adult animals.
b. Development of dopamine neurons.
Based on the precise work of Lauder and Bloom (437) using 3 H-thymidine labeling, dopamine neurons in the substantia nigra undergo differentiation between E12 and E15 with a peak event occurring on E13. This finding is in good agreement with more recent studies in embryonic rats that dopamine neurons are not seen in the brain or the hypothalamus until E15-E17 (440) . There is a very rapid increase in dopamine content in the diencephalon of rats between E15 and E17, followed by a gradual postnatal increase through P18 when adult levels
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TERASAWA AND FERNANDEZ Vol. 22, No. 1 are reached (440) . This time period (P0 -P18) corresponds to the development of the tubero-infundibular dopaminergic system. In humans, dopamine neurons first appear in the ventricular floor at E week 6. By E week 8 they start to extend neurites, which reach the striatum at E week 10 (469, 470). In rhesus monkeys dopamine neurons originate from the ventricular zone of the fourth ventricle between E36 and E43 with peak neurogenesis at E38 -E40 (454) . TH is detected in the mesencephalon and diencephalon at E38, its mRNA in the mesencephalon is observed at E40 (471), and TH immunopositive cells and fibers are present in the substantia nigra and the developing striatum, respectively, at E40 -E41 (454, 471) . By E60 the size and number of TH immunopositive neurons in the caudal diencephalon and midbrain increase (454, 471) , but there are no TH-immunopositive cells in the arcuate nucleus at this age (471) . Apparently, arcuate dopamine neurons are also last to develop in rats and sheep (472, 473) . The increase in the cell size of dopamine neurons continues until P60 in monkeys (454) .
There are gender differences in embryonic development of dopamine neurons. Dopamine-immunopositive neurons from the E14 female rat brain after 3 days in vitro have a morphologically more mature appearance than those from the E14 male brain, and have much higher rates of dopamine reuptake, an indicator of activity and maturity, than male neurons (474) . These results indicate that diencephalic dopaminergic neurons in the female mature sooner than in the male and that the differences are not steroid-dependent as the initiation of testosterone secretion does not occur until E17-E18, and incubation of these neurons with androgen or estrogen has no effect on their morphology, development, or activity.
c. Dopamine concentrations and turnover rates.
Earlier data indicate that dopamine levels in the rat brain increase from birth to adulthood (428, 441, 443) . However, more recent data show that dopamine concentrations and turnover rates specifically increase before or around the age of puberty. In the MPOA, dopamine concentrations are low in P15 rats and increase from P20 to adult levels by P25 in female rats. In addition, turnover rates of dopamine in the MPOA are low in P15 rats, start to increase at P20 through P25-P35, and then decrease by P40 when turnover rates reach adult levels (444, 457) . In the hypothalamus, dopamine levels are significantly higher at P30 -P40 than at P10 -P30 (450) , and dopamine turnover rates increase before first early proestrous but decline at first late proestrus (457) . Further, the higher dopamine levels in the hypothalamus in rats with posterior hypothalamic lesions exhibiting precocious puberty and in control rats on the day of vaginal opening compared with prepubertal control rats (451) suggest a role for dopamine in puberty. However, dopamine turnover rates in the MPOA do not change when estrogen induces an LH surge in P15 female rats, unlike increases in NE turnover rates with the same treatments and with the proestrous surge, indicating that dopamine may not be critically involved in the first LHRH surge (453) . Rather, it is likely that a developmental increase in turnover rates in prepubertal rats is due to increased levels of circulating PRL (453, 475, 476 ).
d. The dopamine synthesizing enzyme, TH, and its activity.
TH activity in the MPOA and MBH, including the arcuate nucleus and median eminence, of female rats is low at P5-P10, increases at P15-P20 by 2-to 3-fold, remains stable until P35, and increases further after P40, reaching adult levels (456, 477) . TH activity in the MBH does not change after P40 in males (477) .
Similar developmental changes in TH mRNA and protein expression in the arcuate nucleus occur in both males and females (477) . TH mRNA levels in the arcuate nucleus increase 3.5-fold between P5 and P15 and remain steady between P15 and P35 in both sexes, but a further increase between P35 and P40 occurs in females, but not in males, concomitant with the increase in circulating progesterone. Immunostaining intensity of TH in the arcuate nucleus also undergoes similar developmental changes. TH-containing cells in the zona incerta (A13 cell group) are already present at E16 and E20, and both TH mRNA levels and the intensity of immunostaining for TH in the zona incerta and substantia nigra increase between P5 and P15 in both sexes, with no further increase between P20 and P70 (477 (478) . Similarly, no labeling for dopaminergic D 2 receptors is seen in the hypothalamus between E16 and E18, but by E19 -E20, D 2 receptor labeling is seen in the anterior hypothalamic area in rats (435, 479). By E22-P0, the dorsomedial hypothalamus expresses [
125 I]sulfiride labeling, and by P7 the lateral POA begins to exhibit some labeling, although no additional changes occur through P21 (479). D 2 -dopamine binding sites in the hypothalamus increase from P5-P15 in rats (480) . Neither SCH-23390 nor sulfiride has any effect on LHRH release from primary hypothalamic cells obtained from E16 rat embryos cultured for 12 days in vitro (434). These results indicate that dopamine receptors are not likely involved in LHRH release until after the second week of postnatal life. In support of this view, treatment with pergolide, a D 1 and D 2 agonist, only at P11-P20, but not P1-P10, results in precocious puberty in female rats by desensitization of dopamine receptors (466, 481) . With the approach of puberty, changes in dopamine receptors appear to occur. For instance, there is a slight increase in the number of dopamine D 1 and D 2 receptors in the striatum and an increase in D 1 receptors in the nucleus accumbens in female rats between P20 and P40 (482) . D 1 receptor numbers in the nucleus accumbens decrease after P40 and through P80, to final adult levels, but 6 , and 5-HT 7 have been described (485) . Serotonin can be stimulatory or inhibitory to the control of reproductive function (465) . A decrease in serotonin synthesis with p-chlorophenylalanine (PCPA) blocks the proestrous LH surge (486) , several serotonin antagonists suppress spontaneous ovulation as well as PMSG-induced ovulation in immature rats (487, 488) , and lesions of the medial and/or dorsal raphe with the neurotoxin 5,7-dihydroxytryptophan (5,7-DHT) result in blockade of PMSG-induced first ovulation (489) or delay the onset of puberty (490, 491) . Elevations of serotonin concentrations in the hypothalamus of female rats and in the median eminence in chicks are associated with the first proestrus and precocious puberty, respectively (487, 492) , and serotonin concentrations in the hypothalamus-POA are lower in female rats exhibiting delayed puberty induced by growth deficiency and environmental stress than in normal controls (493) . In contrast, the pharmacological elevation of serotonin in the hypothalamus with monoamine oxidase inhibitors suppresses spontaneous ovulation in adult rats (494) and PMSG-induced ovulation in immature female rats (495) . Although stimulatory and inhibitory roles of serotonin in gonadotropin secretion and puberty may be attributable to the anatomical differences in two serotoninergic systems, such that the dorsal raphe nucleus plays a stimulatory role and the medial raphe nucleus plays an inhibitory role (496) , it is possible that the gonadal state and developmental age may influence serotonin action. In fact, serotonin stimulates LH release in female rats at P16 -P20, whereas it does not alter LH release in female rats at P26 (497) , and serotonin inhibits LH release in castrated male rats, whereas it stimulates LH release in intact male rats (498) .
The role of serotonin in puberty in primates is not well investigated. In adult female rhesus monkeys, however, Bethea and colleagues extensively studied regulation of the serotonin neuronal system by the ovarian steroid hormones (499 -503).
Neuropeptide Y (NPY)
. NPY, a 36-amino acid peptide, is one of the most abundant peptides found in the mammalian central nervous system and plays several important roles in regulating brain function, including control of reproductive function and food intake behaviors. Physiological roles of NPY in the brain are mediated by NPY receptors that belong to a family of G protein-coupled transmembrane spanning molecules, and at least six receptor subtypes (Y1-Y6) are identified. The Y1, Y2, Y5, and Y6 receptors also mediate the effects of the structurally related peptide YY (PYY). Different classes of receptors have been suggested to be involved in different functions of NPY.
a. Developmental changes in NPY and NPY receptors.
Development of the NPY neuronal system appears to closely parallel the development of the LHRH neuronal system, suggesting a potential interaction between the two neuronal systems (504) . For example in the chick, a population of NPY-positive neurons originates beginning at embryonic stage 28 in the olfactory placode, whereas LHRH neurons differentiate at stage 25 (505) . A large percentage of NPY neurons coexpressing LHRH migrate into the brain with LHRH neurons (505) . However, the majority of NPY neurons originate within the brain. In rats, NPY neurons are already present in the diencephalon and brainstem at E13-E14 (506), the developmental stage during which LHRH neurons are first found in the basal forebrain (507), although NPY neurons are not detectable in the cerebral cortex, hippocampus, and mesencephalon until E16-E19 (506, 508, 509) . Concentrations of NPY in these brain areas increase 1.5-to 5-fold at birth with the rate of increase in the diencephalon being the largest.
Biochemical, molecular biological, and neuroanatomical studies show that postnatal development of NPY in the brain either increases or decreases or does not change. NPY contents in the hypothalamus increase during postnatal development in rats (511, 512) . NPY concentrations and NPY mRNA levels in the medulla oblongata, cerebral cortex, and hippocampus in rats and in the cortex in monkey also increase postnatally (506, 510, 513) . Further, according to Sutton and colleagues (511) , NPY levels in the MBH and MPOA increase steadily from birth to P20 in males and from birth to P36 in female rats, and plasma levels of NPY in the hypothalamic-hypophyseal portal circulation collected on the day before vaginal opening are significantly higher than those collected 2 days before vaginal opening, coinciding with the peak of the LH surge. In female rhesus monkeys as well, NPY release in the S-ME increases along with the pubertal increases in LHRH release (514) . In contrast, a recent study in male monkeys indicates that NPY concentrations and mRNA levels in the MBH increase between the neonatal and juvenile periods, whereas both decrease between the juvenile period and puberty in male monkeys (238), and expression of NPY mRNA in the arcuate nucleus and VMH also decrease between the juvenile period and puberty (238). Similarly, in rats and pigs, neuroanatomical studies indicate that the number of immunopositive NPY neurons in the hypothalamic nuclei, such as the arcuate nucleus and paraventricular nucleus, as well as cerebral cortex, is largest at birth and declines during postnatal development (508, 509, 515) . However, some reports also show that NPY concentrations in the diencephalon and brainstem do not change postnatally (506, 510) , and a neuroanatomical report also indicates that no postnatal changes occur in the number of immunopositive NPY neurons in the hypothalamus, including the proportion of neuroendocrine NPY neurons, which send their axoterminals to the median eminence (516 (520) .
In mice, using RNase protection assays, Y1, Y2, and Y5 mRNAs are expressed very early in the developing spinal cord, brain, cerebellum, and dorsal root ganglion and are often down-regulated at times corresponding to their acquisition of the adult function in neurotransmission. In situ hybridization of the adult brain shows that Y1 is widely expressed, Y2 displays a more restricted pattern, Y5 is expressed at very low levels and only in a few brain nuclei, and Y6 is not expressed. Virtually all areas containing neurons positive for Y5 also express Y1, and many Y1-positive cells clearly express Y5. In contrast, Y2 is not expressed by neurons expressing Y1 or Y5. These observations suggest that NPY signaling in the brain can be mediated by simultaneous Y1 and Y5 activation (521) .
b. Stimulatory role of NPY in puberty.
The role of NPY in the control of reproduction and LHRH release has been discussed extensively (417, [522] [523] [524] . Numerous earlier studies indicate that NPY is inhibitory in OVX rats, rabbits, sheep, and monkeys (525) (526) (527) (528) (529) , whereas it is stimulatory in ovarian intact or estrogen-primed adult rats (see Ref. 523 ). However, in our studies NPY is a stimulatory neuromodulator for LHRH release regardless of the gonadal state of adult female monkeys (Fig. 2) . NPY pulses in the S-ME occur with 5 min preceding LHRH pulses (530) , and NPY infusion into the S-ME increases LHRH release in a dose-responsive manner (531) , whereas infusion of NPY antiserum suppresses LHRH pulses (530) . Interestingly, estrogen facilitates NPY action, i.e., the dose-response curve of NPY is left-shifted by estrogen priming (532) . The difference between earlier studies in another laboratory (528) and ours was due, perhaps, to technical differences. Since studies in other laboratories examined the effects of NPY with intraventricular (lateral ventricle) infusion, it is possible that NPY might have stimulated neurons inhibitory to LHRH release, such as ␤-END neurons, by diffusion through the ventricular system. In fact, recent studies suggest that NPY is stimulatory if it is applied to the median eminence directly in vivo or in vitro in OVX rats and monkeys and GT-1 cells (533) (534) (535) (536) . Nonetheless, a more recent study suggests that NPY is obligatory to the full expression of the estrogen-induced LH surge, since the magnitude of the LH surge is significantly less in NPY knockout mice than in normal mice (537) .
A line of study indicates that NPY is involved in the mechanism of the onset of puberty in chickens, rats, and monkeys. The hypothalamic content of NPY increases during postnatal development until the age of puberty (511, 512, 517 ). An increase in NPY mRNA levels and NPY concentrations in the MBH and MPOA occurs in P29 rats treated with estrogen and progesterone, which is followed by a decrease after the LH surge, and the changes in NPY mRNA and NPY concentrations in the MBH and MPOA are parallel to those with LHRH mRNA and LHRH concentrations (538, 539) . Intraventricular infusion of a NPY antiserum delays the timing of puberty in female rats (540) , whereas a single intraventricular injection of NPY advances vaginal opening followed by first ovulation in female rats (541), and 5-day injection of NPY into the lateral ventricle of chicks induces precocious puberty with an increase in food intake (542) . In contrast, chronic infusion of 18 g NPY into the lateral ventricle starting on P30 delays sexual maturation in female rats with a decrease in food intake, whereas a single injection of 12 g NPY into the lateral ventricle does not result in any significant effect (543) . In food-restricted rats with delayed puberty, NPY injection results in an increase in food intake and rapid restoration of body weight followed by puberty (544) . Thus, NPY appears to possess both stimulatory and inhibitory effects, interacting with other neuronal systems, such as leptin neurons, that control food intake behavior and energy balance (545) . Because ventricular infusion allows NPY to diffuse elsewhere in the brain, further studies are needed to clarify the inhibitory mechanism of NPY in puberty.
We have also examined the role of NPY in puberty. NPY infusion into the S-ME stimulates LHRH release in pubertal female monkeys, but not in prepubertal monkeys (514) . Similarly, NPY antiserum infusion into the S-ME suppresses LHRH release in pubertal monkeys, but not in prepubertal monkeys (514) . The mean NPY release is low in prepubertal monkeys, when LHRH release is low, and an increase in NPY occurs along with the pubertal increase in LHRH release (514) . Moreover, in a subsequent experiment, a graft of the adrenal medulla, which contains NPY and NE, into the third ventricle of prepubertal female monkeys adjacent to LHRH neurons and their neuroterminals resulted in the advancement of ovulation, but not menarche (433). We have interpreted these results to mean that NPY may be a contributing neuromodulator for puberty, rather than a key factor to trigger the onset of puberty, since neither NPY nor NPY anti-
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NEUROBIOLOGY OF PUBERTYserum is effective in altering LHRH release before the onset of puberty (Table 2) . However, if NPY is an inhibitory neuromodulator in the prepubertal period as proposed by Plant and colleagues (see below), it is possible that infusion of the NPY antiserum for 10 min in the previous study may not have been sufficient for an increase in LHRH release. The question as to whether NPY is inhibitory to LHRH release before the onset of puberty and reverses its function to stimulatory after the onset of puberty remains to be answered.
c. Inhibitory role of NPY in puberty.
An inhibitory role for NPY has been reported in rats (546) . Recently, Plant and colleagues reported that NPY mRNA levels in the hypothalamus, measured by RNase protection assay, decreased at the onset of puberty in male castrated monkeys concomitant with an increase in LHRH mRNA levels (Ref. 238 and Fig. 2 ). These authors further reported that NPY mRNA expression in neonatal males was lower than in prepubertal juvenile males, although LHRH mRNA expression in neonates was not different from that in prepubertal juveniles (547) , and infusion of an NPY antagonist into the ventricle stimulated LH release (238). Similarly, chronic infusion of NPY into the lateral ventricle starting on P30 delays sexual maturation in female rats concomitant with a decrease in food intake (543) , which is likely mediated by NPY-Y 5 receptors (548). These observations are particularly interesting, since it has been reported that NPY colocalizes in GABA neurons in the cerebral cortex, hippocampus, suprachiasmatic nucleus, and arcuate nucleus (549 -551) . NPY is inhibitory to hippocampal and suprachiasmatic neurons via presynaptic or postsynaptic receptors (552) (553) (554) (555) , and studies in NPY knockout mice indicate that NPY is an endogenous antiepileptic agent through presynaptic inhibition of glutamate neurons (556, 557) .
Nonetheless, the inhibitory role of NPY in the mechanism of the onset of puberty in rhesus monkeys requires further evaluation: 1) NPY release in the S-ME increases at the onset of puberty in female rhesus monkeys (514) , whereas GABA release decreases concomitantly with the pubertal increase in LHRH release in prepubertal females (217, 240); and 2) infusion of an NPY antiserum to the S-ME suppresses LHRH release in pubertal females, but not in prepubertal females (514) , whereas the GABA A antagonist, bicuculline, stimulates LHRH release in prepubertal monkeys (217). Presently, it is unclear whether the discrepancy between female and male monkeys is due to sex differences or to methodological differences. In males, neither developmental changes in release of LHRH and NPY nor the effect of NPY infusion into the S-ME on LHRH release have been investigated; reports from the Plant laboratory have not been confirmed by others. Further, developmental changes in NPY mRNA in the female hypothalamus have not been assessed. If there is any inhibitory role of NPY in puberty (Table 1) , the clarification of the issues, such as 1) whether NPY action is direct on LHRH neurons or indirect through interneurons; 2) if it is direct action, whether the site of NPY action is on the LHRH perikarya or their neuroterminals; and 3) whether two subsets of NPY neurons (one is stimulatory and the other is inhibitory to LHRH release), as proposed by Plant and colleagues (558) are present will be critical to understanding its mechanism.
Other neuropeptides.
a. Galanin. Galanin that colocalizes in a subset of LHRH neurons in the rat (559, 560) has been reported to play a role in modulating pulsatile LHRH release and the mechanism of the onset of puberty (561, 562) . Galanin concentrations in the hypothalamus increase with precocious puberty induced by PMSG in female rats (563) , and galanin mRNA levels in the bed nucleus of the stria terminalis and medial amygdala, and galanin binding levels in the POA increase across puberty in both male and female rats (564 -566) . Specifically, galanin mRNA levels in LHRH neurons increase at puberty 8-and 2-fold in female and male rats, respectively, and this increase is due to gonadal steroids (567) . Interestingly, perikarya of galanin neurons are innervated by NPY neurons (568) . However, galanin neither colocalizes in LHRH neurons nor stimulates LHRH release in monkeys (569) and does not appear to play a significant role in the control of LHRH neurosecretion (570) . Therefore, it is not likely that galanin plays any role in puberty in primates.
b. LHRH. It has been shown that LHRH controls the secretory pattern of LHRH neurons. For instance, GT-1 cells release LHRH into media in a pulsatile manner indicating that LHRH itself may be a regulator of pulsatility. A study using GT-1 cells suggests that LHRH controls the mechanism generating LHRH pulses: exposure to the LHRH agonist analog, des-Gly 10 (d-Ala 6 ) LHRH, stimulates the amplitude of intracellular Ca 2ϩ oscillations and LHRH pulses in a concentration-related manner, while the frequency of LHRH pulses is reciprocally reduced with an increase in concentrations of the analog (571) . The findings that LHRH receptor mRNA containing neurons are distributed in the same area that LHRH neurons are present (572) , and that LHRH neurons express LHRH receptors (573) , suggest that there is an autocrine mechanism, i.e., that LHRH release is controlled by LHRH itself. Therefore, it is possible that a small increase in LHRH release in the hypothalamus may augment LHRH release further during the progress of puberty. Despite the fact that in-depth discussion on the autocrine action of LHRH is available in reviews by Stojilkovic and colleagues (574, 575) , as well as by Terasawa (576) , the role of LHRH in the pubertal increase in LHRH release has not been investigated thus far.
C. Role of glia and growth factors
Recently, the role of glia and growth factors from glia has become an important issue in the control of LHRH release and the onset of puberty. Glia can contribute to the control of the pulsatility of LHRH release by 1) modifying the local environment of the release site in the S-ME, where there is an abundance of neuroterminals and glial cells, including tanycytes, but not cell bodies of LHRH neurons (577-580); 2) producing growth factors (see below); and 3) providing a signaling pathway from other neurons, e.g., the neuroligand, bradykinin, stimulates glutamate release from astrocytes, which in turn appear to signal back to bradykinin neurons (582, 583) . A critical role of glia in release of oxytocin and vasopressin has been well documented (584 -586) .
Astroglia synthesize and release growth factors, such as transforming growth factor-␣ and -␤ (TGF␣ and TGF␤, respectively). The presence of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), IGF-I, neuronal cell adhesion molecule (NCAM), cytokines, such as interleukin-1 (IL-1) and IL-6, and diffusible substances such as nitric oxide (NO) have been reported in astrocytes (see Ref. 587) , and these substances appear to alter LHRH release. Because several excellent reviews are available on this topic (588 -593) , in this article we will only summarize the recent findings.
Expression of TGF␣ mRNA in astrocytes increases with normal puberty as well as precocious puberty induced by hypothalamic lesions in female rats (594, 595) . These authors speculate that lesions of the POA-hypothalamus induce astrogliosis, which is responsible for the increase in TGF␣ in the hypothalamus. TGF␣ also stimulates LHRH release and increases glial secretion of PGE 2 (596) , which, in turn, mediates the stimulatory effect of NE on LHRH release, as discussed above. Cultured hypothalamic astrocytes treated with estradiol yield a conditioned medium that stimulates the production of PGE 2 receptors on GT1 cells, although there appear to be factors other than astrocytes, as yet unidentified, that enhance LHRH release (597) , because the astrocyte-conditioned medium is more effective in inducing LHRH release than simply the addition of PGE 2 to the medium (598). EGF receptors have been shown to mediate the effects of TGF␣, and EGF receptor mRNA and EGF protein expression appear to decrease before the first preovulatory LHRH surge, indicating a possible role for EGF in the onset of puberty (599) . Similarly, TGF␤ derived from astroglia stimulates LHRH mRNA levels and release from GT1 cells (600, 601) . Because astroglia contain LHRH-degrading enzymes as well as a 5␣-reductase (601), it is possible that they may play a role in mediating steroid action on LHRH release (602) .
bFGF is a potent mitogen and neurotropic factor for hypothalamic neurons (594, 603, 604) as well as for GT1 cells stimulating LHRH release (605) in vitro. bFGF alters the secretion of LHRH from GT1 cells by inducing the secretion of intermediate products from the posttranslational processing of LHRH rather than the completely processed decapeptide (606) . bFGF mRNA levels in the MBH, but not in the cerebral cortex, significantly decrease with puberty (first ovulation) induced by NMDA or PMSG in female rats, whereas bFGF receptor mRNA levels in the MBH and cortex show no change (607) . Further, the number of bFGF-positive cells in the arcuate nucleus is significantly higher in NMDA-treated rats at P29 before puberty as compared with saline-treated controls at the same age, and the number of bFGF-positive cells is significantly lower in NMDA-treated rats at P33 after first ovulation as compared with saline-treated controls at P33 (607) .
It is possible that glia also may play a role in the onset of puberty in rhesus monkeys. TGF␣ mRNA in the monkey hypothalamus increases with puberty (608) . A larger area of glial ensheathment is present on the perikaryal membrane of LHRH neurons in early pubertal monkeys than in adult monkeys (56). However, additional information is needed to establish the critical involvement of glia in the mechanism of puberty, because it is uncertain whether gliosis occurs in the primate hypothalamus before the onset of spontaneous puberty, and because the anatomical difference seen in prepubertal and adult monkeys could be due to the difference in circulating gonadal steroids, as a similar anatomical difference was observed in gonadectomized monkeys vs. gonadal intact monkeys (579) . In addition, the importance of regionspecific neuronal networks is not accounted for in the glia hypothesis of puberty. Lesions in two different regions of the hypothalamus induce similar massive gliosis, yet the effects on the timing of puberty are completely different. For instance, lesions in the posterior hypothalamus-premamillary area result in precocious puberty (83, 609), whereas lesions of an area that includes the posterior median eminence and arcuate nucleus delay puberty, even though the LHRH neurosecretory system is spared (610) .
Using NLT cell line cells carrying a human LHRH transcript (611), Radovick and colleagues (612) report that LHRH neurons contain IGF-I receptors, and that IGF-I is capable of regulating LHRH mRNA expression directly through the AP-1 transcription factor. Thus, it is plausible that the pubertal increase in IGF-I may directly alter activity of the LHRH neurons, and this mechanism may contribute to the pubertal increase in LHRH release, although it is doubtful that IGF-I plays a role in triggering the onset of puberty.
D. Nutritional and metabolic factors
The timing of puberty is influenced by some metabolic cues. For example, in many species 1) puberty usually occurs at a time when the body is reaching adult proportions; 2) undernutrition can delay the onset of puberty; and 3) chronic undernutrition can cause the adult reproductive axis to return to the prepubertal state (see Ref. 613) . Nutritional status, especially energy availability caused by low energy intake or high energy expenditure, has long been known to affect reproductive function (614) . Interference with glucose metabolism, whether via food restriction or antagonism of glycolysis, suppresses LH release in adult as well as in sexually immature animals of a variety of species (615) (616) (617) (618) (619) (620) . However, little is known about how nutritional status determines the timing of puberty. Because several excellent reviews are available on this subject (545, 614, 621-624), we will briefly highlight recent key findings.
A series of studies by Cameron and colleagues (614, 625) suggest that in primates there is a dynamic mechanism, sensitive to energy availability, for the control of reproductive function and puberty. Specifically, in male monkeys, missing a single meal results in a suppression of LH and testosterone secretion within the first 4 h, and refeeding immediately restores normal hormone secretions. However, metabolic signals to the hypothalamo-pituitary-gonadal axis are not mediated by circulating hormones such as insulin, cortisol, adrenal corticosterone-stimulating hormone, and endogenous opioids to the hypothalamus (614, 626 -629). They are
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NEUROBIOLOGY OF PUBERTYrather mediated by neuronal input through the nucleus of the solitary tract in the brainstem (614, 630, 631) . Further, metabolic signals such as the glucoprivic suppression of LH pulses are mediated by the paraventricular nucleus via NE neurons (620) . NE in the paraventricular nucleus increases after injection of the glycolysis inhibitor, 2-deoxyglucose, concomitant with decreases in LH concentrations, whereas injection of the NE synthesis inhibitor ␣-methyl-p-tyrosine prevents these changes (620) . Although additional information is required, LHRH neurons are directly or indirectly affected by poor nutrition. Distribution of LHRH neurons in the hypothalamus of food-restricted prepubertal female lambs is different from the distribution of LHRH neurons seen in control females, and the distribution of neurons in the food-restricted lambs more closely resembles that of fetal lambs, while the distribution of neurons in the control lambs is similar to that seen in adult sheep (632) . Recently, it has been suggested that leptin, a peptide synthesized in adipose tissue and secreted into the general circulation, is a key metabolic mediator for the reproductive neuroendocrine axis. Because extensive reviews on the role of leptin in reproduction as well as in puberty are available (633-637), we will only discuss this topic briefly. Circulating leptin concentration increases and leptin binding activity decreases with puberty (638 -641). Further, leptin induces precocious puberty in mice (642, 643) and prevents the delay in the onset of puberty in underfed female rats (644, 645) . Leptin in food-deprived male rhesus monkeys stimulates an increase in LH pulse frequency, amplitude, and mean concentrations (646) , indicating that leptin may provide information to the brain about nutritional status. The effect of leptin on LHRH release is indirect through other neurons, as no leptin receptor mRNA is found in LHRH neurons, but it is found in NPY and POMC neurons (646) . Since both leptin mRNA and protein are present in neurons in the hypothalamus of rats (647) , it is possible that neuronally derived leptin, in addition to transported leptin from peripheral tissues, plays a role in leptin-induced changes in LHRH secretion. Nonetheless, there are a large number of reports indicating that leptin concentration does not change with puberty in monkeys and humans (Refs. 648 -651, and E. Terasawa, unpublished data), and the timing of puberty is not altered in patients with leptin deficiency who received recombinant leptin (652) . Therefore, leptin is an important peripheral signal for the brain, but it may not be critical for the timing of puberty.
In this article we did not discuss the interaction between the pubertal activation of LHRH neurons and somatic growth, which is controlled by GH, and hypothalamic neuropeptides, including GH-releasing hormone (GHRH) and somatostatin. This is due to the complexity of these two systems and also to a relatively unexplored area of research on the control of GH secretion at the onset of puberty.
VI. Master Gene(s) Controlling the Onset of Puberty
The age of puberty is specific to each species during its life span. Further, many genes in the brain are turned on or turned off to establish a complex series of events occurring during puberty. Therefore, it is not unreasonable to propose the hypothesis that a master gene determines the timing of puberty. It is also possible that multiple master genes could be involved in the mechanism of the onset of puberty, or perhaps body clock genes involved in events during the entire life span determine the timing of puberty. Although causes of human clinical cases of precocious or delayed puberty are largely heterogeneous (1, 2) , and it may not be feasible to pinpoint the presence of master gene(s) at the present time, evidence to support this concept is just emerging in rodent studies. In light of the tantalizing possibility that a master gene(s) may control puberty, a brief summary of current findings is described below.
A recent study by Ojeda and colleagues (653) suggests that at least the Oct-2 POU domain gene is involved in puberty. Because Oct-2, a POU-II class protein (654) , is expressed in the postnatal brain, especially unique in the hypothalamus (654), these authors (653) have examined its role in puberty. Results are summarized thus: 1) three alternatively spliced forms of the Oct-2 gene, Oct-2a, Oct-2b, and Oct-2c, are found in the rat hypothalamus after lesions of the anterior hypothalamus, known to result in precocious puberty; 2) the time course of changes in mRNA levels of each variant after the anterior hypothalamic lesion differs, with expression of Oct-2a mRNA levels being maximal at 8 h after the lesion, Oct-2c transcripts transiently increasing between 48 -72 h, and Oct-2b mRNA levels only changing 4 -5 days after the lesion; 3) anterior hypothalamic lesion-induced astroglia coexpress both TGFa and Oct-2 proteins; 4) an increase in Oct-2a mRNA levels occurs during the early phase of the onset of puberty, whereas an increase in Oct-2c mRNA levels occurs coinciding with the first LH surge; and 5) infusion of an antisense oligodeoxynucleotide for Oct-2 delays the timing of puberty in female rats. Because the TGF␣ promoter contains an octamer-like motif and a (OCTA-) TAATGARAT motif, the authors speculate that Oct-2a and Oct-2c may trans-activate TGF␣ transcription, leading to puberty. It is possible that Oct-1 and Tst-1/SCIP, POU-II and POU-III class proteins, respectively (654), may be involved in the mechanism of the onset of puberty, since Oct-1 activates the neuronspecific enhancer of the LHRH gene (655), Tst-1/SCIP represses transcriptional activity of the LHRH gene (656) , and both mRNAs are present in the adult brain (654) . While the results of these studies are exciting and have provided a novel concept on the mechanism of pubertal development, several caveats should be kept in mind. The studies were conducted in rats, in which the mechanism of the onset of puberty differs from that in primates. The results are inconclusive, and these homeobox genes are not necessarily master genes, and further upstream gene(s) may be present. Nonetheless, the search for a master gene(s) that controls the timing of puberty will be a major task in the new century.
VII. Summary and Conclusions
A summary of the possible mechanism of the onset of puberty in primates is illustrated in Fig. 3 . The LHRH pulsegenerating system is reasonably mature at birth and is al-
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TERASAWA AND FERNANDEZ Vol. 22, No. 1 ready active during the neonatal period. However, in primates "central inhibition" suppresses pulsatile LHRH release during the juvenile period, whereas central inhibition is not apparent in nonprimates. When approaching puberty, in primates this central inhibition is removed or diminished, and an increase in LHRH release occurs, whereas in nonprimates disinhibition may not be critical for a developmental increase in LHRH release. This pubertal increase in LHRH release results in a cascade of events during puberty, such as increases in synthesis and release of gonadotropins, and increases in steroidogenesis and gametogenesis, followed by the appearance of secondary sexual characteristics. The nature of the central inhibition and neural substrates responsible for central inhibition in primates are still unclear. Recent studies from our laboratory suggest that disinhibition of LHRH neurons from GABA appears to be a critical factor in female rhesus monkeys, although other neural substrates, such as NPY, could be involved in this central inhibition. After the central inhibition is removed, however, increases in stimulatory input from glutamatergic neurons as well as new stimulatory input from NE and NPY neurons and inhibitory input from ␤-END neurons to the LHRH neuronal system appear to occur, until the adult type of regulatory mechanism for pulsatile LHRH release is established. Understanding the mechanism of the onset of puberty in detail is very important, because many neurological disorders in humans stem from the changes that occur during the pubertal period. Nonetheless, the most important question still remains: What determines the timing to remove central inhibition? Because many genes in the brain are turned on or turned off to establish a complex series of events occurring during puberty, the timing of spontaneous puberty must be regulated by a master gene or genes, as a part of developmental events. We expect that future studies will include a search for genes determining events to remove central inhibition and master genes that ultimately trigger the onset of puberty in primates. Predominant GABAergic inhibition on LHRH neurons through GABA A receptors appears to keep LHRH release low in prepubertal monkeys. During the prepubertal stage, GABA release is elevated in the S-ME, because of elevated GABA synthesis and less active GABA transporter (GAT). GABA inhibition on LHRH neurons may be direct or indirect through glutamatergic neurons. At the onset of puberty, decreases in GABA release and an increase in GAT activity in the S-ME result in the dominant state of glutamatergic neurons. Thus, the reduction in GABA and the increase in glutamate induce the pubertal increase in LHRH release, which triggers a cascade of events at puberty, i.e., an increase in gonadotropin secretion, followed by an increase in gonadal steroids, which results in the appearance of secondary sex characteristics. As puberty progresses, other neurotransmitter systems, such as the stimulatory NPY and NE neuronal systems, and the inhibitory opioid neuronal systems participate in the control of LHRH release. During this period, ovarian steroids are also involved in the establishment of the adult type of pulsatile LHRH release. A possible role of glia in puberty is also illustrated (see details in text). The GABAergic control of gonadotropin-releasing hormone secretion in male rats during sexual maturation involves effects on hypothalamic excitatory and inhibitory amino acid systems. Neuroendocrinology 64:305-312 306. 
